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An approach that has been widely applied for the genetic dissection of 
complex traits is Quantitative Trait Locus (QTL) mapping. QTL mapping identifies 
genomic regions that harbor polymorphisms, responsible for the observed 
variation in a complex trait. If these polymorphisms are located within a gene, 
then these genes are called Quantitative Trait Genes (QTG). Prior to 
advancements in QTL mapping populations, QTL mapping resolution was often 
poor, resulting in large QTL intervals. Therefore, after mapping a QTL, fine 
mapping was initiated to further reduce the QTL interval and to identify the QTG. 
While successful, fine mapping using genetic approaches have been extremely 
time and resource intensive, making it the rate-limiting step in QTG discovery. 
Thus far, only a few QTGs have been successfully identified and validated. The 
disproportionate ratio of QTLs mapped to QTGs identified has been a cause of 
concern.   
Successful QTG discovery relies on the power and resolution with which 
QTLs are mapped and the genetic architecture of the underlying QTL mapping 
population. Here, QTL mapping performance in two recently developed QTL 
mapping populations, namely the expanded BXD Recombinant Inbred (RI) strain 
panel and the collaborative cross (CC) are assessed. Results indicate that while 
both the expanded BXD RI strain panel and the CC improve QTL mapping 
resolution, the CC is able to achieve greater precision and resolution in QTL 
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mapping.  However, neither the BXD RI nor the CC facilitates gene level 
resolution in QTL mapping.  
Recent studies have used the integration and convergence of evidence 
among functional genomics studies as a successful strategy towards the efficient 
and rapid nomination of QTG. Here, the complementary in silico approach of 
integrative functional genomics, using GeneWeaver (www.geneweaver.org), is 
applied towards the reduction of two cocaine-induced locomotor activation QTLs, 
mapped in the expanded BXD RI strain panel. Integrative functional genomic 
analyses of these QTLs led to the nomination of Rab3b as a putative QTG. 
Functional assessment of Rab3b using Rab3bcd knockout mice reveals its role in 
acute habituation mediated cocaine response, serving as evidence of the 
efficiency and utility of integrative functional genomics for the identification of 
highly relevant QTG. 
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 1 
CHAPTER I: INTRODUCTION  
 
 This dissertation illustrates the progress that has been made to address 
the challenge of identifying quantitative trait genes (QTG) underlying complex 
traits. Identification of QTG has relied heavily on the technique of quantitative 
trait locus (QTL) mapping. However, the power and resolution of detecting QTL 
and thereby QTG, depends on the nature of the experimental crosses or genetic 
reference populations (GRPs) used. To improve upon the prospects of identifying 
QTGs using QTL mapping, advances in GRPs have been made. The studies 
presented here help assess the performance of QTL mapping and prospects of 
QTG discovery in two GRPs, namely the expanded BXD Recombinant Inbred 
(RI) strain panel (Chapter II) and the collaborative cross (CC) GRP (Chapter III). 
While advances in GRPs have improved the performance of QTL mapping, gene 
level resolution is still not attainable. Hence, after a QTL has been mapped 
additional fine mapping is required to identify the QTG. Even though, fine 
mapping has been successful in identifying QTG, it is an extremely time and 
resource intensive process. To expedite the discovery of QTGs, complementary 
bioinformatic and computational approaches have been proposed, with limited 
success. In Chapter IV, the in silico approach of integrative functional genomics 
is proposed as a complementary approach to fine mapping and existing 
bioinformatic approaches and is applied towards the behavior of cocaine-induced 
activation for the nomination and validation of a putative QTG.  
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Background 
Tremendous success has been achieved in understanding the genetic 
basis of a variety of complex human diseases and disorders. Part of this success 
is attributable to the field of behavioral quantitative trait genetics. Utilizing 
induced organismal models of complex human disorders, behavioral genetics 
aims to understand the genetic basis of quantitative traits and mechanisms that 
facilitate interactions between organisms and their environments. Among the 
variety of model organisms available, Mus musculus has been widely used to 
study both simple, Mendelian diseases (e.g. cystic fibrosis (174), Hermansky-
Pudlak syndrome (69) and Waardenburg syndrome (141)) and complex 
multigenic disorders (e.g. alcohol preference (75, 177, 225), diabetes (207) and 
bipolar disorders (65, 128)). The high degree of homology between human and 
mouse genomes, availability of basic and advanced genomic tools, resources 
and decades of research findings are some of the reasons for the widespread 
use of Mus musculus as a model organism.  
Studies involving mice as models for human disorders dates back to the 
strains of mice and document spontaneously arising mutations. Since then inbred 
strains of mice have been the mainstay of mouse genetics. They have been used 
as founders for the derivation of quantitative trait mapping populations (e.g. F2, 
BC and genetic reference populations), which have been utilized in complex trait 
analysis. Despite the availability of inbred strains, mapping populations and 
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mapped using mice. This occurred as a consequence of the development of 
statistical methodologies along with the availability of large collections of 
molecular tools and/or genetic markers facilitating the association of trait 
variation to genetic variation. Furthermore, these methodologies permitted, albeit 
crudely, the estimation of genomic regions responsible for complex traits. This 
led to the development of the field of quantitative trait locus (QTL) mapping. 
Advances in genomic resources and statistical methodologies, even 
though extremely beneficial, have resulted in the current situation that plagues 
the field of QTL mapping, i.e., far more QTLs than QTG. The low turnover ratio of 
QTL to QTG has raised doubts about the utility of QTL mapping with proposals of 
alternate approaches such as ENU mutagenesis (148) in identifying genes 
underlying complex traits. While such concerns are reasonable, the rate-limiting 
step in the identification of QTG is not the QTL mapping process, but rather the 
lack of an efficient and rapid methodology that facilitates reduction of a QTL 
interval to nominate a QTG. While expansions (e.g. recent expansion of the BXD 
RI strain panel (162)) and advances (e.g. collaborative cross (42)) in genetic 
reference populations will improve precision and resolution in QTL mapping, 
complementary computationally efficient approaches that facilitate QTG 
discovery must be developed.  One such approach is integrative functional 
genomics, which provides a robust, efficient and scalable framework within which 
the reduction of a QTL interval to highly relevant QTG can be achieved. 
Furthermore, integrative functional genomics allows analyses to be performed 
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across multiple species and experimental data types, thereby implicitly facilitating 
translation research. 
Quantitative trait locus mapping 
Behavioral quantitative trait genetics aims to achieve a better 
understanding of the genetic basis of behavior. To do so one must associate 
phenotypic variation in behavior to genetic or sequence variation. Genetic 
variation comes in the form of segregating polymorphisms. A widely used 
statistical method that facilitates detection of genomic regions that are 
significantly associated with phenotypic variation is QTL mapping. The concept of 
QTL mapping was first defined by K. Sax in 1923 (181). QTL mapping belongs to 
the class of genome-wide scanning approaches rather than a candidate gene 
approach. Unlike the candidate gene approach, genome-wide scanning 
approaches make no presumptions regarding the importance of any particular 
gene or genes for the phenotype being investigated. As a result, QTL mapping is 
a truly unbiased approach that helps facilitate the discovery of polymorphisms 
associated with a given phenotype.  
Methods for mapping QTL 
QTL mapping is often carried out in populations that originate from 
crosses of inbred lines that differ phenotypically for the trait of interest. As these 
lines are inbred, they are homozygous at all loci (markers and QTL) of their 
respective genomes. The first filial (F1) generation involving these inbred lines 
will be heterozygous and genetically identical across all loci. F1 progeny can then 
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be either backcrossed to one of the two parents generating a backcross (BC) 
population or sib mated to generate a second filial (F2) population. Both the BC 
and the F2 populations consist of genetically diverse individuals, who also exhibit 
phenotypic variation and are consequently extremely useful in QTL mapping. 
Another valuable and widely used population for QTL mapping is the panel of 
recombinant inbred lines (RILs). RILs are derived from twenty or more 
generations of inbreeding via full sibling matings or selfing in plants, starting with 
an F2 population. During the process of inbreeding, the genomes of the F2 
progeny undergo recombination, resulting in the creation of RILs that are 
genomic mosaics of their founders. Historically, RILs have proven to be 
extremely useful in mapping QTL in multiple model organisms, including, M. 
musculus, C. elegans and D. melanogaster. Once a QTL mapping population 
has been derived, the next steps involves phenotyping and genotyping all 
individuals within the population. This is followed by application of one of two 
statistical methods for mapping QTL, namely, single marker analysis or interval 
mapping. 
Single-marker analysis 
Single-marker analysis is the simplest approach to QTL mapping 
(15, 223). This approach utilizes an analysis of variance (ANOVA) methodology, 
also referred to as marker regression. In this method, the genotypes at a QTL 
marker are separated into their respective groups. If one were to consider a BC 
mapping population, individuals within this mapping population can be divided 
 6 
into one of two groups, namely, homozygotes or heterozygotes. Statistical tests 
for strength of evidence of a QTL are then carried out either using a t-test or an 
F-test depending upon the type of cross. The primary advantage of single marker 
analysis is its simplicity. However, this approach has multiple limitations. First, 
this approach fails to account for recombination between a marker and a QTL. 
Second, incorrect estimates of QTL location can be obtained, especially when a 
marker is far way from the true QTL. Third, individuals with missing genotypes 
have to be omitted from the analysis.  
Interval mapping 
  Interval mapping was developed in order to over come the 
simplistic nature of single marker analysis (114). Interval mapping incorporates 
the genetic map of the markers and interrogates the genome at regular intervals 
for the evidence of a QTL. By calculating a LOD (logarithm of odds favoring the 
presence of a QTL) score across the genome, interval mapping generates a LOD 
curve (Figure 1-1). In Figure 1-1, the LOD curve at its maximum point indicates 
the most likely location of a QTL. Using either 1-, 1.5- or 2-LOD drops from the 
peak marker, an estimated location or confidence interval (CI) of a QTL is 
obtained. The 1.5-LOD drop is the most widely used, as it corresponds to an 
approximately 95% QTL CI (61), However, careful attention should be paid 
towards the selection of LOD drop based CI as it depends largely on the QTL 
effect size and marker density. The main advantage of interval mapping over 




Figure 1-1. A typical QTL LOD curve.  
Data plotted here are a significant Chr 5 QTL from the experiment of Boyartchuk 
and colleagues on the susceptibility to Listeria monocytogenes infection in the 
mouse using R/QTL (22, 27). The solid, dotted and dashed lines represent 
permutation based significance and suggestive thresholds. Vertical ticks on the 
x-axis represents genotyped marker on Chr 5 in this study. 














1.5 LOD ( ~95% CI)  
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interval mapping imputes the missing genotype using the flanking markers rather 
than discard the individual. The observed LOD score (obtained using the actual 
mapping dataset) is then compared to the distribution of peak LOD scores 
obtained following interval mapping on each permuted dataset. QTL significance 
is then determined based on the proportion of permuted LOD scores exceeding 
the observed LOD score, giving an estimated p value. It should be noted that the 
distribution of a LOD scores obtained during a permutation analysis is influenced 
by the type of cross, number of markers, the inter-marker interval, missing 
genotypic data patterns and the original or observed phenotypic distribution (26). 
This was shown by Lander and Botstein (114), who performed a variety of 
simulation estimating the LOD threshold as a function of cross type, genome 
sizes and marker density. Depending on the cross type, a map expansion factor 
of 1 (BC), 2 (F2) or 4 (RIL) needs to be incorporated into the calculation of LOD 
scores (114). The permutation approach put forth by Churchill and Doerge can 
be applied to any mapping dataset, regardless of the distribution of the 
underlying data. However, this approach must be used appropriately, taking into 
account the underlying population or family structure of the mapping population. 
Failing to do so will result in incorrect estimates of significance thresholds leading 
to inflated type I error rates in QTL mapping.  Specifically, simple permutations 
described above cannot be applied without modifications to mapping populations 
such as advanced intercross lines (AIL) and heterogeneous stock (HS). In such 
mapping populations, due to their inherent population structure, approaches such 
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as mixed model association (103) or model averaging approaches (214) are 
employed to map QTL after taking into account the population structure.  
From QTL to quantitative trait genes  
Advances in genotyping and phenotyping technologies have resulted in an 
exponential increase in the number of published QTLs. However, very little 
progress has been made in the positional cloning or identification of the relevant 
gene(s) affecting complex traits. As of today over 4,600 QTLs exists. Of these 
QTLs only 20 genes have been nominated and validated as QTG (74, 138). The 
current miniscule ratio of QTG to QTL has raised concerns about the utility of 
QTL mapping for dissecting complex traits (148). The reasons why little progress 
has been made in the identification of QTG include: 
• The majority of the cloned QTLs to date have been QTL with unusually 
large effect sizes (74). However, QTLs typically have small effect 
sizes, thereby making them harder to dissect and clone. It is not 
reasonable to expect that experimental procedures used to clone large 
effect QTL will also be both applicable and successful for small effect 
QTL. Unlike large effect QTL, small effect QTL are driven by multiple 
linked loci, thereby requiring many more recombinants to successfully 
isolate a single gene. For example, a genetic strategy employing 
congenic strain pairs will not successfully clone small effect QTLs. 
Interval specific congenics could probably facilitate cloning of small 
effect QTLs, but would require large numbers of recombinant progeny. 
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• It has been reported that the underlying molecular basis of QTL are 
often due to non-coding regulatory variants compared to coding 
regulatory variants (107, 129). Unlike coding regulatory variants that 
would result in a missense, nonsense or some other form of easily 
detectable polymorphism, non-coding regulatory variations are harder 
to detect and validate. 
• Lastly, a typical QTL interval width can span tens of cM. A typical QTL 
interval in mice spans 10 – 30 cM or approximately 20 to 60 Mb (78). 
Multiple factors affect the QTL interval, including, marker density, 
phenotypic variance accounted for by the QTL, and the type of cross.  
Large QTL intervals will invariably contain hundreds of genes (also 
called candidate genes), making it tedious and painstaking to identify 
the causative gene or genes. 
Methodologies that currently exist for the nomination of QTGs can be 
classified into two main categories, namely, genetic and bioinformatic 
approaches.  
Genetic approaches 
Genetic approaches facilitate QTG nomination by making use of the 
concept of homologous recombination. Using homologous recombination, the 
original QTL region is reduced to a narrower region consisting of a handful of 
potential QTG. Classical approaches include congenic strain pairs, chromosome 
substitution strains, advanced intercross lines and heterogeneous stock. In 
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addition to classical approaches, newer genetic approaches have been 
developed that include collaborative cross and Diversity outbred. 
Existing mouse genetic resources 
Congenic strain pairs and interval specific congenics 
Congenic strain pairs or congenics have been the most 
widely used resource for fine-mapping QTL. Congenics are derived from two 
inbred strains, a donor and recipient strain, which differ on the trait of interest. 
The progenitors strains are crossed to produce the F1 generation progeny. F1 
progeny carrying the donor region of interest are selected for and backcrossed to 
the recipient strain. At least ten generations of backcrossing to the recipient 
strain is performed to reduce the amounts of donor strain genome, such that 
99.9% of the genome in the progeny is recipient derived. At this generation, the 
residual amount of unlinked donor strain genome is < 0.01%. This is done in 
linked to the donor strain region of interest. The presence of hitchhiking genes in 
the recipient genome would very easily lead us to the wrong conclusion and in 
the failure to capture the true QTL. At the end of backcrossing, heterozygous 
congenics are intercrossed to obtain homozygous congenics. The primary 
drawback of classical congenics is that the donor strain interval tends to be too 
large, often around 50 Mb, and is often dissected into several linked QTLs (169, 
170). If these linked QTLs exert opposite effects on the phenotype, then the 
identification of the causative gene(s) involved becomes even more difficult (60, 
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237). Furthermore, isolating a QTL onto a recipient strain can result in a 
reduction in the effect size compared to the originally mapped QTL. This would 
further complicate the identification of the causative gene(s). In order to 
overcome these limitations, interval specific congenics (ISC) were developed. 
Backcrossing the congenics or consomics to the background strain of interest 
serves as the first step in the derivation of ISC. Some among the first generation 
(N1) offspring will be recombinant within the original interval of interest, i.e. the 
QTL interval. These offspring are identified using markers that reside within or 
flank the QTL interval. Once these individuals are identified, further refinement of 
the interval of interest is achieved by backcrossing to the background strain. 
Once the maximum amount of interval refinement has been achieved, 
backcrossing generates a panel of ISC lines. At this stage the ISCLs are 
heterozygous at the region of interest. In order to obtain ISCLs that are 
homozygous for the donor regions, the heterozygous mice are intercrossed. 
Phenotyping the ISCL facilitates detection of narrow genomic regions positively 
associated with or manifesting the QTL of interest.  
 The use of ISCLs often achieves fine mapping of the original QTL to 1-2 
Mb. This results in only a handful of potentially causative genes to follow-up, 
thereby facilitating QTG discovery. Mpdz (189), II-2 (55) and Kcnj10 (71) are 
QTGs that have been identified using the ISC approach in mice, while Cyp11b1 
(44) is an example of application of the ISC approach in rats. Despite its 
theoretical simplicity and feasibility, this approach has multiple challenges and 
drawbacks. First, there is a good chance that the QTL of interest might not be 
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captured due to loss of an epistatic interaction or closely linked QTL that exists 
with the original QTL. Secondly, it takes a considerable amount of time and 
resources to generate sufficient numbers of ISCs to successfully identify a single 
candidate gene or gene variant that defines the QTL. 
Chromosome substitution strains 
   Chromosome substitution strains (CSSs) or consomics 
strains have been proposed as a means to achieve the genetic dissection of a 
QTL. Transferring an entire chromosome from a donor strain onto a background 
strain by repeated backcrossing generates CSS strains (134, 149). The first 
complete set of CSS created was from the two inbred strains A/J (donor) and 
C57BL/6J (background) (192, 193). While CSS have been used to dissect QTL, 
they have also been utilized to map QTLs. This is because a CSS panel has the 
advantage of mapping QTLs that explain a greater proportion of the total 
phenotypic variance or QTL effect size and the ability to employ lower 
significance thresholds towards the detection of significant QTLs. Their utility in 
high-resolution mapping is made possible in two ways, through rapid creation of 
interval specific congenic lines and recombinant progeny testing (RPT) (50). By 
backcrossing the CSS that harbors the QTL followed by intercrossing the F1 
progeny, a congenic (smaller introgressed intervals in comparison to the original 
CSS) F2 population is created. A new set of ISC is created from the congenic F2 
population followed by high-resolution mapping. In RPT, animals that are 
recombinant in the QTL region of interest are backcrossed to a background strain 
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that helps in the identification of the QTL location relative to the site of 
recombination (19, 68).  
 Despite the ease with which one can map and generate a CSS panel, they 
suffer from a major limitation, i.e. their inability to facilitate the dissection of large 
effect QTLs into many loci smaller of effects. This hinders the ability with which 
smaller effects QTLs can be fine-mapped using this resource.  
Advanced intercross lines 
   Advanced intercross lines (AIL) facilitate refinement in QTL 
mapping by introducing new recombinations via intercrossing (51). Starting with a 
F2 population, intercrossing is typically performed for eight or more generations 
(to arrive at F10), by randomly intercrossing progeny in each generation to 
produce the next. Careful attention is paid towards the selection of mice that 
produce the next generation by avoiding sib-pairs and cousins. This is done in an 
attempt to maintain a randomly mating population and avoid fixation (due to 
inbreeding) of alleles so as to maintain maximum genotypic diversity. Increased 
numbers of recombinant progeny within an AIL facilitates high-resolution 
mapping of QTLs. It has been shown that for a QTL with large effect mapped in a 
large population (N = 1500), an AIL (greater than F10) achieves a QTL CI of 
approximately 5 cM compared to 14.8 cM in an F2 population (51). Furthermore, 
AILs can help resolve closely linked QTLs. For example, if two QTLs are closely 
linked (approximately 5 cM apart), an F2 population will fail to dissect them. 
However, in an AIL at F10 these loci are predicted to be 26 cM apart facilitating 
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detection of both loci and thereby resolving linked QTLs (51). Numerous studies 
have made use of AILs for fine-mapping QTLs (67, 94, 180, 199, 220, 221, 234, 
238). Despite the advantages offered by an AIL, the primary disadvantage is the 
inherent presence of family structure that exists at the final generation of AILs. 
Family structure or non-independence among individuals due to the complex 
breeding history of AILs, when unaccounted for, results in detection of spurious 
QTLs (160). Statistical methods have been devised to account for family 
structure and must be utilized when an AIL is used for fine-mapping a QTL (104, 
153, 214). 
Heterogeneous stock 
A series of repeated intercrosses involving inbred strains of 
mice results in the derivation of the heterogeneous stock (HS). Existing HS have 
been derived from an initial cross involving eight progenitor strains. Currently, 
two HS panels exist: the Boulder IBG heterogeneous stock (136) has been in 
existence for over 60 generations and is derived from the C57BL/6, BALB/c, RIII, 
AKR, DBA/2, I, A/J and C3/HeJ strains and the Northport heterogeneous stock 
(53) that has been in existence for over 40 generations and is derived from the 
A/J, AKR/J, BALB/cJ, C3H/HeJ, CBA/J, DBA/2J and LP/J strains. New 
recombinations are introduced by using a pseudo-random breeding protocol of 
circle mating. The increase in numbers of recombinations results in higher-
resolution mapping. In order to map traits using the HS, specialized statistical 
methodologies are utilized that incorporate the probability that an allele descends 
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from one of the eight progenitor strains followed by association of these alleles to 
the phenotype of interest (145). The fine-grained mosaic of the HS along with 
specialized statistical methods has facilitated high-resolution QTL to within 1 cM 
for several behavioral measures (90, 131, 145, 204, 205, 230). The primary 
disadvantages of the HS lie in the complexity of the mapping analysis, 
requirement of high-density genotyping and large mapping sample sizes required 
to fine-map QTLs (144). 
Emerging mouse genetic resources 
Collaborative cross 
The collaborative cross (CC) is an emerging mouse genetic 
recombinant inbred (RI) panel that is derived combining the genomes of eight 
genetically diverse founder strains, namely, A/J, C57BL/6J, 129S1/SvImJ, 
NOD/LtJ, NZO/HlLtJ, CAST/EiJ, PWK/PhJ, and WSB/EiJ (42). When completed 
the CC will be the largest RI panel, vastly exceeding the genotypic and 
phenotypic variation captured in currently existing RI panel such as the BXD RI. 
Like the HS, the CC is a fine-grained mosaic of genomes of eight inbred strains 
with increased recombinations facilitating high-resolution QTL mapping. Studies 
involving the interim CC lines have validated increased precision and resolution 
in QTL mapping and vastly increased phenotypic variation across multiple 
phenotypes compared to existing RI panels (8, 62, 165). The limitations of this 
strategy are primarily due to the complexity of mapping and interpretation of 
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mapping results. Furthermore, despite improvements in resolution of QTLs, 
single gene identification is yet to be achieved.  
Diversity outbred  
   Originating from a set of 160 breeding lines that founded the 
CC population, the DO is produced by an outbreeding rather than an inbreeding 
strategy (41). The DO breeding design ensures a balanced contribution of the 
founder genomes and at the same time is shielded from the consequences of 
inbreeding, such as allele purging. As the DO is outbred, the mice within this 
population will be heterozygous, thereby incorporating high levels of allelic 
variation and genetic diversity. The high levels of genetic diversity in the DO are 
comparable to that in humans, making the DO an extremely useful resource for 
the study of complex human disorders.  
Bioinformatic approaches 
Challenges in transitioning from QTL to QTG have led to the development 
of complementary bioinformatic approaches that facilitate QTG nomination. 
Bioinformatic approaches incorporate publicly available genomic resources that 
include sequence and gene expression databases to refine and narrow a QTL 
interval (57).  
Comparative genomics 
  Comparative genomics takes advantage of the structural 
conservation of genomes across mammals, specifically those that have been 
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used in QTL mapping. Human and mouse genomes have similar genomic 
contents and linear arrangement of genes (222). Furthermore, over 300 genomic 
segments with conserved synteny have been identified in whole-genome 
comparison of humans and mouse (163). Comparison of human and rat 
genomes have revealed similar results (155). By searching for overlapping QTL 
regions for the same phenotype across multiple species, comparative genomics 
has been used successfully to narrow large QTL intervals. Identification of Rf-1 
(renal failure-1) is an example of the successful application of this approach for 
the reduction in the QTL interval. Using synteny between the rat and human 
genome, this QTL was reduced to a set of 66 highly likely candidate diseases 
genes. This strategy has also been used for the identification of candidate gene 
loci for male fertility (156) and reduction of QTL interval for HDL cholesterol 
levels (30, 47). The biggest challenge with this strategy is when a rodent QTL 
maps to multiple syntenic blocks along the human genome instead of one 
contiguous block, making it harder to detect the true homologous gene. 
Combined cross analysis 
  Combined cross analysis works on the assumption that when the 
same causal polymorphism and gene underlies a QTL that has been mapped in 
multiple crosses, by combining these crosses one increases the number of 
recombination events in the combined cross panel thereby achieving increased 
resolution or reduction in the QTL interval. Furthermore, combining multiple 
crosses results in an increase in the mapping sample size, facilitating increased 
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power in the detection and resolution of QTLs with small effect sizes (121). This 
strategy has been successfully applied in achieving better QTL mapping 
resolution across diverse traits, such as HDL cholesterol (47, 201, 224) and ear 
hole punch healing (39) in mice and experimental autoimmune encephalomyelitis 
in rats (96). Limitations of this strategy stem primarily from the fact that not all 
QTL have been mapped in multiple crosses. Most of the multiple cross studies 
involve the analysis of cholesterol levels, making it the most feasible trait to be 
employed in a combined cross analysis. Care should also be taken to ensure that 
the phenotype or trait mapped across the multiple crosses is the same. 
Combining diverse phenotypic data across multiple crosses will produce spurious 
results. 
Haplotype association mapping 
  Haplotype association mapping (HAM) stems from the concept of 
genomic segments sharing polymorphisms that in turn are associated with 
common ancestral origins. These genomic segments are often referred to as 
haplotype blocks. Two methods of HAM exist, namely, interval-specific haplotype 
analysis and genome-wide haplotype analysis. 
Interval-specific haplotype analysis 
   Here, an underlying QTL detected in a two strain mapping 
study is mapped back to their respective ancestral subspecies of origin. If the 
QTL region is identical by descent (IBD) i.e., originating from a common 
ancestral subspecies, then it is unlikely to contain the causal genetic 
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polymorphism. This strategy has been applied towards the genetic dissection of 
rodent QTLs. A metastasis QTL on Chr 19 was reduced from over 400 genes to 
around 23 genes (158). Another example is of a blood pressure QTL on Chr 1 
that was originally around 42 cM but was refined to an interval of 2.3 cM (56). A 
more recent example of a behavioral trait that was refined is of open field 
behavior, wherein, by employing multiple crosses and interval specific haplotype 
analysis, an approximately 50 Mb region was refined to a 7.8 Mb region on Chr 9 
(66). 
Genome-wide haplotype analysis 
   Contrary to interval-specific haplotype analysis, genome 
wide haplotype analysis is performed in the absence of the a priori knowledge 
that is obtained from a QTL mapping study. Also known as in silico QTL 
mapping, genome-wide haplotype analysis seeks to associate phenotype 
variation across a panel of inbred strains to their genotypes rather than to a 
mapping population derived from inbred strains. Grupe and colleagues (83) were 
the first to develop the methodology behind in silico QTL mapping. Using this 
methodology Smith and colleagues (195) were the first to perform in silico QTL 
mapping of atherosclerosis susceptibility across six inbred strains.  
The concept and use of HAM in QTL mapping has been rather 
controversial. Questions have been raised regarding the actual sample sizes or 
number of strains and the basis of the statistical approach (35, 49). Even in the 
light of these controversies, HAM has been utilized for narrowing QTL intervals of 
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HDL-C concentration on Chr 8 (167) and Chr 5 (221). Pletcher and colleagues 
used HAM to identify a single candidate gene containing a non-synonymous 
polymorphism, starting from a QTL that spanned 5 Mb (167). Wang and 
colleagues used a combination of AIL first refine the QTL interval from 8.6 Mb to 
2.6 Mb. Using HAM, the authors were able to further refine this QTL to a 0.4 Mb 
region (221). HAM has also been used for the identification of candidate lung 
tumor susceptibility genes by refine the original QTL interval to < 0.5 Mb (123) 
and in the detection of Cer1 as a potential candidate for bone mineral density 
(BMD) regulation across a panel of inbred strains. By studying CER1 in Chinese 
populations with high and low BMD, the authors were able to detect a non-
synonymous polymorphism within CER1 that conferred an increased risk of low 
BMD in premenopausal women and an increased risk of vertebral fractures in 
postmenopausal women (206).  
Sequence and gene expression comparison 
Variation present within a QTL interval could either be due to 
differences in the gene sequence or expression. As a result, sequence 
comparison and gene expression analyses have been performed in order to 
detect the most plausible QTG. The recently completed next-generation 
sequencing (NGS) by the Sanger Center Mouse Genomes Project has made 
available the genomes of 17 inbred mouse strains commonly used in QTL 
mapping at very high resolutions (105, 231). This will result in the detection of 
large insertion/deletions, copy number variations (CNVs) and other types of 
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sequence variants that will help facilitate QTG discovery (105, 217, 231). The 
advantage of sequence analysis is in its ability to identify sequence differences 
that may not lie within the coding region of the gene (229). 
In addition to sequence comparisons, gene expression analyses serves as 
a complementary strategy for the identification of QTGs. The idea behind gene 
expression analyses is that a QTL will contain genes that harbor sequence 
polymorphisms that effect gene function, expression or both. The availability of 
public gene expression databases, such as The Gene Expression Omnibus (64), 
Array Express (23), The Alan Brain Atlas (1, 118), BioGPS (200), ExQuest (28) 
and The Institute for Genome Research (2), facilitate tissue specific gene 
expression and differential expression analyses. However, due to the large 
numbers of gene expression differences exhibited by murine strains, fine-
mapping will be necessary (138).  
Characteristics of genes affecting quantitative traits 
Glazier and colleagues (78) and The Complex Trait Consortium (CTC) (5), 
have proposed a sets of guidelines or standards to characterize a gene as the 
QTG. Listed below is a summarization of the characteristics of a QTG: 
• The QTL that contains the potential QTG should meet statistically 
significant genome-wide thresholds (58, 113). In the absence of clear 
genome-wide significance from a single study, the QTL should meet 
consistent suggestive genome-wide thresholds across multiple 
independent studies. 
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• Polymorphisms within a QTG, either in the coding or non-coding region, 
should translate into changes in either the structure or expression of the 
gene product. Coding sequence non-synonymous polymorphisms are the 
easiest class of polymorphisms to detect and validate. Synonymous 
coding region polymorphisms have been linked to differential mRNA 
stability. Intronic (non-coding) or promoter region polymorphisms could be 
detected as changes in mRNA splicing and transcription factor binding 
(130). Even though salient, these changes could potentially affect the 
amount, timing and tissue specific pattern of gene expression  
• In vivo confirmation of a QTG via alteration of its function should be 
obtained. This can be performed using one of many strategies, namely, 
targeted gene mutations such as knockouts or deficiency-
complementation tests, transgenesis, viral-mediated RNA interference 
(RNAi) and knock-ins. 
For a gene to be proven to be the QTG it must possess more than one of the 
above stated QTG characteristics. In the absence of a clear and significant 
empirical result that proves a gene as the QTG, preponderance of circumstantial 
evidence will cumulatively work towards the nomination of a QTG.  
Integrative functional genomics  
 To truly expedite the process of QTG discovery, the vast repertoire 
of genomic resources and datasets currently available, need to be harnessed 
and utilized efficiently. Currently two popular approaches exist that help integrate 
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diverse genomic data sets, namely, meta-analysis and convergent functional 
genomics.  Meta-analysis is a statistical approach that analyzes large collections 
of experimental data with the goal of integrating experimental results and findings 
(77). Meta-analysis has been applied to a wide array of genomic data sets, such 
as, microarrays (112, 143, 146, 147, 172, 173) and QTL mapping studies (17, 
185, 228). Convergent functional genomics (CFG) is a Bayesian strategy that 
facilitates integration of gene expression data across human linkage analysis and 
relevant animal models (150). CFG has been successfully applied towards the 
identification of candidate genes and blood biomarkers for bipolar disorder (111, 
116, 159). Despite the successes of meta-analysis and CFG, both approaches 
lack computationally efficient infrastructures in the form of databases, algorithms 
and user interfaces that facilitates genome scale integrative analyses in a 
seamless and scalable manner. Furthermore, while CFG integrates human and 
rodent data sets, meta-analysis fails to attain cross-species analysis. Given that 
many model organisms have their genomes sequenced, it would be beneficial for 
integrative approaches to encompass more than just two species. Additionally, 
CFG is tailored towards the needs of a specific laboratory and/or specific 
research area.   
 To truly expedite the process of QTG discovery, computationally efficient 
algorithms, databases and user-interfaces need to developed and utilized. One 
such approach is integrative functional genomics. Integrative functional genomics 
facilitates convergent analyses across multiple genomic experiments, platforms 
and species (11), thereby readily lending itself towards the discovery of QTGs. 
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Candidate genes within a QTL interval can be integrated with other relevant 
empirically derived genomic data sets or gene sets. The gene sets to be used in 
the analysis are selected based on the trait in which the QTL was detected. For 
example, an integrative functional genomic analysis for a cocaine-induced 
locomotor response QTL will include gene sets spanning multiple species for 
basal expression across brain reward regions, differential gene expression 
across brain reward regions for stimulants that influence brain reward regions 
(such as methamphetamines and nicotine), previously mapped QTL studies 
involving cocaine-induced locomotion and polymorphism information for the 
genes across the founder strains. A ranked list (based on occurrence count 
across genomic data sources) of candidate genes can be obtained to prioritize 
genes for future validation studies. Such an analysis approach will yield highly 
relevant polymorphic genes that can be functionally validated and eventually 
nominated as a QTG. 
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CHAPTER II: QTL MAPPING AND QTG DISCOVERY IN EXISTING 
GENETIC REFERENCE POPULATIONS 
 
This chapter is adapted from the following publication: 
Philip VM, Duvvuru S, Gomero B, Ansah TA, Blaha CD, Cook MN, Hamre KM, 
Lariviere WR, Matthews DB, Mittleman G, Goldowitz D, Chesler EJ. 
Genes, Brain and Behavior (2010) 9: 129-59.  
My contributions to this paper were heritability analysis, QTL mapping, gene co-
expression analysis, gene-phenotype combinatorial analysis, KEGG and GO 
pathway analysis, interpretation of results, and part of the writing. 
Abstract 
Genetic reference populations, particularly the BXD recombinant inbred 
(BXD RI) strains derived from C57BL/6J and DBA/2J mice, are a valuable 
resource for the discovery of the bio-molecular substrates and genetic drivers 
that mirror complex human disorders such as drug addiction and alcoholism. The 
initial set of BXD RI strain panel consisted of only a limited number of strains 
(approximately 30). The combination of a limited number of strains and sparse 
marker maps resulted in low QTL mapping precision and resolution. In 2004, the 
BXD RI strain panel underwent a large expansion resulting in the addition of 46 
new BXD RI strains, making it the largest genetic reference population. 
Furthermore, the expanded BXD RI strain panel has increased numbers of 
recombination events resulting in improved precision and resolution in QTL 
mapping. Additionally, the presence of approximately 1.8 million SNPs between 
C57BL/6J and DBA/2J strains greatly improves the prospects of QTG nomination 
and validation. 
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Using the recently expanded BXD RI strain panel, members of the 
Tennessee Mouse Genome Consortium (TMGC) have obtained phenotype data 
from over 250 measures related to multiple behavioral assays across several 
batteries: response to, and withdrawal from cocaine, MDMA, morphine and 
alcohol; novelty seeking; behavioral despair and related neurological 
phenomena; pain sensitivity; stress sensitivity; anxiety; hyperactivity; and 
sleep/wake cycles. All traits have been measured in both sexes in approximately 
70 strains of the recently expanded panel of BXD recombinant inbred strains. 
Sex differences and heritability estimates were obtained for each trait, and a 
comparison of early (n = 32) and recent (n = 37) BXD RI lines was performed. 
Primary data is publicly available for heritability, sex difference and genetic 
analyses using the MouseTrack database, and is also available in 
GeneNetwork.org for QTL detection and genetic analysis of gene expression. 
Together with the results of related studies, these data form a public resource for 
integrative systems genetic analysis of neurobehavioral traits.  
Introduction 
genetic reference populations (GRP) for linkage analysis (191). Once 
established, a GRP can be used repeatedly over time and across laboratory 
environments primarily due to their genetic stability. Recombinant inbred (RI) 
strains are an example of a GRP. RI strains were initially used to map single loci 
associated with Mendelian traits. However, over the last few decades, RI strains 
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have also become an invaluable tool for the genetic dissection of complex traits 
(168). The construction of an RI strain panel is initiated by selecting two highly 
inbred progenitor strains that typically vary for a trait of interest. These 
progenitors are intercrossed to form the F1 progeny. At the F1 generation, all 
offspring are heterozygous and genetically identical. F1 progeny are crossed to 
produce the F2 generation in which, due to meiotic recombination, random 
rearrangement of the progenitor genomes occur. At the F2 generation, randomly 
chosen pairs of animals are used as founders for subsequent derivation of RI 
strains of mice. Performing brother-sister mating for at least 20 generations 
eventually produces RI strains. After 20 sequential rounds of brother-sister 
mating, the genomes of these RI strains are essentially fixed (approximately 99% 
homozygosity) (162). This creates panels of RI strains wherein individuals within 
any given strain are genetically identical to each other. Figure 2-1 illustrates the 
process of creation of the BXD RI strain panel, the largest and most widely used 
RI panel. 
Properties of a RI strain panel 
Due to the process of inbreeding, RI strains are fixed and homozygous at 
maintained at the inbred homozygous state by continuation of brother-sister 
mating as long as required. RI strains have three primary advantages over an F2 
or BC. First, as they are genetically stable, experimental results obtained across 
these panels can be compared across time and laboratories (82). Second, 
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Figure 2-1. Construction of a RI strain panel. 
Derivation of the BXD RI strain panel starts with intercrossing C57BL/6J (B) and 
DBA/2J (D) inbred strains of mice. Three pairs of F2 siblings are randomly 
chosen as founders for three resultant BXD RI strains called BXD 1, BXD 2 and 
BXD 100. 
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multiple experimental observations can be obtained per strain therefore 
facilitating replication and increased statistical power (16). Thirdly, due to their 
fixed genomes, genotyping is required only once, thereby greatly reducing 
genotyping costs.  
Initial BXD RI strains and behavior genetics 
Given the above-mentioned advantages of RI strains, it is not surprising 
that they been often used in studying quantitative traits. Among the panels of 
RIstrains currently available, BXD RI strains are the largest (Table 2-1). The BXD 
RI strain panel was first established by B. A. Taylor in 1977 (208) and expanded 
to 35 strains in 1999 (209). The earliest reports of RI strains, specifically the BXD 
RI strain panel, in the genetic dissection of behavioral traits dates back to the 
(48, 135, 186). Even though early studies were limited in their power 
to detect QTLs, due to the limited numbers of strains utilized (approximately 20 
or fewer strains), the advantages and utility of a relatively small RI strain panel 
called for the generation of larger RI strain panels (168).  
Expanded BXD RI strain set 
In 2004, Pierce and colleagues expanded the existing BXD RI strain set to 
a total of 79 strains (162). These strains were derived from an advanced 
intercross (AI) between C57BL/6J (B) and DBA/2J (D) progenitor strains. As 
these new BXD strains were derived from AI lines (also termed BXD ARI), they 
have increased numbers of recombinations, facilitating improved mapping 
resolution (162, 187). Pierce and colleagues have estimated that the number of 
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recombinations detectable in the 46 BXD ARI lines is equivalent to at least 90 
BXD RI strains generated from an F2 population. Furthermore, the BXD ARI lines 
are able to detect QTLs accounting for half the amount of genetic variance 
compared to the BXD RI lines (24% compared to 47%) (162). Using this 
expanded strain set will facilitate detection of QTLs explaining small effects (at 
least 10% genetic variation) to 1  2 Mb intervals (162). Another advantageous 
property of the BXD RI strain panel is that the B6 and D2 progenitor strains 
havebeen deeply sequenced facilitating the discovery of 1.8 million SNPs. These 
progenitor strain differences used in concert with BXD RI genotypes permits the 
discovery of coding sequence variants, such as SNPs and insertion-deletions. 
Despite the utility of RI strains in studying complex traits, their use has 
been limited to only a few areas, such as basal behaviors and ethanol related 
traits. Furthermore, in most cases, only one sex was studied. To truly harness 
the power of the largest RI strain population currently available, it is vital to 
employ high-throughput behavioral phenotyping techniques that facilitate quick 
and accurate measurements of behavior. This is particularly of great importance, 
given the derivation of RI strain panels, such as the CC, that are expected to be 
4  5 times larger than the BXD RI strain panel. 
Methods 
High-throughput behavioral phenotyping 
In order to rapidly develop a broad base of behavioral phenotyping data, 
phenotyping was performed in several multivariate test batteries. Each battery 
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consists of a set of tests administered serially to individual mice. This approach 
also allows for the examination of partial-correlation within strain (non-genetic 
correlation) but may upwardly bias estimates of genetic correlation obtained 
using strain means of the measures. A given mouse was assigned to one and 
only one battery and received all tests in that battery. The order of repeated 
testing was either fixed where logical and necessary or, in the case of the 
nociception battery, varied systematically using randomly generated Latin-square 
designs each applied to a different strain and sex. In general, for fixed-order 
batteries, the least stressful measures were obtained first, and all baseline 
measures were necessarily obtained before conditioning or drug exposures. The 
testing protocols were largely derivative of those developed in consultation with 
the external advisory board of the Tennessee Mouse Genome Consortium 
(TMGC) ENU-Neuromutagenesis Program (79). Detailed methods of the 
phenotyping protocols are presented elsewhere (164). 
Statistical genetics in the expanded BXD RI strain panel 
Strain effects and sex differences 
Sex, strain and strain ! sex interaction effects were tested using 
non-sequential sums of squares estimation in a general linear model. The model 
used for testing these effects was 
yij i + Sexj + Straini ! Sexj ij, (1) 
Where, yij is the phenotype being measured for Straini and Sexj. In 
addition to testing these effects, we estimated the magnitude of strain, sex and 
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strain ! sex effects by estimating the intra- 2, for each 
2 was estimated as the proportion of variance accounted 
for by the main or interaction effects relative to the total phenotypic variance. All 
variance components were estimated using the REML option of SAS PROC 
VARCOMP. This method can be biased due to departures from normality, a 
common phenomenon for behavioral traits. The percent variance accounted for 
by strain is considered by some to be an estimate of broad-sense heritability (89, 
127) for clones, and is formulated as the strain intra-class correlation: 
h2 2 Between Strain 2 Between Strain 2 Within Strain). (2) 
Standard errors were obtained using an adjustment for unbalanced data 
(202). This calculation was performed for the two sexes separately, and for the 
data combining both sexes. It should be noted that this measure provides an 
estimate of the resemblance among relatives in a population in which 
segregation had occurred and does not reflect the transmission of genetic 
material in a randomly mating population. It is nonetheless an indication of 
suitability and plausibility of genetic analysis for a given phenotype. 
Sub-populations effects 
A limited number of systematic differences exist in the genotypes of the 
old and new BXD RI strains such that loci have been identified that segregate in 
only one of the two sub-populations (187). To test for global phenotypic effects of 
these differences, we use the nested model, 
yij i (Sub-Populationj) + Sub-Populationj ij  
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An alternate F test is applied. The F ratio is MSSub-Population / MSStrain(Sub-
Population). This test is used because the individual mice in the study are not 
independent, but rather are replicates within a strain. Therefore, we use the 
appropriate error term and degrees of freedom for the random effect of strain 
nested within the sub-populations. To account for multiple testing, the false 
discovery rate (FDR) was controlled using q-value estimation for the sex and 
strain main effects and sex ! strain interaction effects. The R/qvalue software 
developed by Storey (198) was used for the analyses. A q-value threshold of 
0.05 was used to identify significant results. Quantitative trait locus mapping was 
also performed separately for sub-populations. 
Comparison of data across time and phenotypes 
To determine if behavioral measures collected across time and 
laboratories can be integrated we correlated saline induced locomotor activity 
and thermal nociception. Saline induced locomotor activity was measured in two 
laboratories in the current study (n = 62), Memphis (locomotion in 15 mins) and 
UTHSC (locomotion in 20 mins). These data were compared to saline-induced 
locomotion measured by Demarest and colleagues in 1999 (n = 25). Thermal 
nociception measured in two laboratories in the current study (n = 62), Memphis 
and ORNL, were compared to Mogil and colleagues (140) and Brigman and 
colleagues (24). 
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QTL mapping and genetic correlations 
GeneNetwork (GeneNetwork.org) serves as a database and analysis 
engine for QTL mapping and genetic correlations among strain phenotypic 
means obtained in the BXD RI reference population. Strain means were 
computed in MouseTrack by sex and other cofactors. For pooled sexes, the 
mean values were the least-squares means with strain, sex and strain ! sex in 
the model. Male and female strain means for each phenotyping battery were 
exported from MouseTrack for submission to GeneNetwork. This enables gene 
expression correlation and interval mapping, candidate gene searches and multi- 
trait analyses. 
Each exported dataset was subject to an interval mapping analysis, which uses 
GeneNetwork’s embedded MapManager software, WebQTL, (132) to perform 
Haley–Knott regression. Empirical p values were derived using 1000 
permutations using the incorporated permutation feature of WebQTL. The peak 
of each statistically significant (p < 0.05) or suggestive (p < 0.63) (113) QTL was 
determined based on empirical p values (58). A one-LOD drop-off was used to 
determine the QTL confidence interval about each peak. Positional candidates 
residing within a one-LOD drop from the peak of each statistically significant and 
suggestive QTL were identified. 
Trait data were correlated against the following GeneNetwork gene 
expression tissue databases: whole brain [INIA Brain mRNA 430 (June 2006) 
RMA (161), neocortex [HQF BXD NeoCortex ILM6v1.1 (February 2008) RankInv 
(76)], striatum [HBP Rosen Striatum M430V2 (April 2005) RMA (178)], 
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cerebellum [SJUT Cerebellum mRNA M430 (March 2005) RMA (32)] and 
hippocampus [Hippocampus Consortium M430V2 (June 2006) RMA (106)]. Lists 
of genes were generated based on their correlation to each phenotype using a 
correlation p value < 0.001. 
Multi-trait QTL mapping 
Multi-trait QTL analysis can be performed by extracting common 
underlying factors from multiple behavioral phenotypes and generating strain-
specific factor scores. The underlying hypothesis of this type of analysis is that 
behavioral measures for stress, anxiety, pain and addiction to drugs of abuse are 
under common genetic control and should share some degree of correlation. 
Brigman and colleagues performed a similar decomposition of anxiety and fear 
behavior in BXD RI mice (24). This approach to multi-trait QTL mapping has also 
been performed by Trullas and Skolnick (212), wherein factor analysis was used 
to report that elevated plus maze behavior predicts anxiety-like behavior, and 
more recently by Henderson and colleagues, who performed QTL mapping on 
multiple phenotypic assays of anxiety-like behavior (87). The value of performing 
such studies in the BXD RI population is that the data can be expanded 
indefinitely with additional independent phenotypic profiling which adds depth 
and detail to the multi-dimensional analysis. 
As the phenotypic data contained missing observations, any strain with 
more than 25% of trait data missing was removed from this analysis. This 
resulted in the elimination of 32 of the 95 BXD strains, giving us an effective 
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sample size of 63 BXD strains. The resultant data set was subjected to column 
mean imputation in order to fill in the missing trait values, given that the data 
were missing at random, i.e. not missing over all measures within a battery. 
Another issue that was encountered during this analysis was that of 
dimensionality. The dataset used in the factor analysis had more variables/traits 
(p) than observations/strains (n) (i.e. n < p). This results in incorrect estimation of 
the covariance matrix and thereby leads to singularity of the estimated 
covariance matrix. This issue was addressed by using the James–Stein-type 
shrinkage estimator (182) of the covariance matrix. R packages e1071 (for 
missing data imputation), corpcor (for covariance shrinkage), nFACTOR and 
factanal were used for the purposes of factor analysis. Factor loadings were 
analyzed to obtain factor interpretations. Factor scores were obtained for all 
interpreted latent factors. Quantitative trait locus mapping was performed on 
these latent factors to identify common genetic drivers of variability in factor 
scores. 
Combinatorial analysis of gene to phenotype associations 
Each set of gene expression correlates with p value < 0.001 for gene–
phenotype association was subject to combinatorial analysis to identify those 
genes that were directly correlated to multiple phenotypes. Positional candidates 
defined as those that reside within a one-LOD support interval of significant (p < 
0.05) or suggestive (p < 0.63) QTL. The top 5 and 10 percent of the highly 
connected genes were analyzed for over-representation of genes in the Kyoto 
 39 
Encyclopedia of Genes and Genomes (KEGG) pathways (101) using the 
analysis tool, WebGestalt (235), which performs a hyper-geometric test for the 
similarity of the list of highly connected genes and the members of curated 
pathways in the KEGG database. The resulting list of enriched categories of 
genes represents those processes, functions and molecular classes that are 
most involved in genetic variation in behavior. 
Results 
Strain effects and sex differences 
Generalized linear models were used to test for sex and strain main 
effects, and sex ! strain interaction effects. False discovery rate analysis was 
used to control the family-wise error rate at 0.05 and showed significant sex 
effects for 97 of the 257 measures with five expected false positives, significant 
strain effects for all 257 measures, and significant sex ! strain interactions for 
144 of the 257 measures with seven expected false positives. In the event that 
there was no trend toward a significant sex difference or interaction, male and 
female data were combined for subsequent QTL mapping and genetic 
correlations. Effect sizes were estimated as partial 2 for the main effects of 
strain and sex, and for the sex ! strain interaction. Consistent with statistically 
significant strain effects, 146 measures under consideration had large effect 
sizes ( 2 !"0#30), 93 had intermediate effect sizes (0#30 !" 2 !"0#10) and 19 had 
small effect sizes ( 2 $"0#10) (Figure 2-2). Locomotor activity in a variety of 
apparatus and under different drug exposure conditions typically had large strain 
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Figure 2-2. Strain intraclass correlation for all measures. 
A histogram of strain intra-class correlations for all behavioral measures (sexes 
combined). A majority of the behavioral measures (146 of 257) have !2 > 0.30, 





effect sizes, consistent with the previous reports (216). Other traits with large 
effect sizes include acoustic startle response, pre-pulse inhibition, morphine 
withdrawal and alcohol withdrawal. Intermediate effect sizes were observed for 
nociception-related traits, morphine side- effects, ethanol-induced ataxia, 
baseline HIC, blood ethanol concentration, cocaine-conditioned place preference 
and anxiety. Only a small number of measures had effect sizes below 0.1. These 
were most often measures derived from linear combinations of two measures, for 
which the expected variance of the derived scores is at least four times the 
variance of either measure alone (98). The 30% effect size is a conventional 
guide for traits amenable to genetic analysis. The proportion of variance 
accounted for by strain varies between the sexes for many traits. For some traits, 
females have a higher proportion of non-genetic variation and for others males 
exhibit more non-genetic variation. Across test batteries, except for adrenal 
weights, the main effect of strain consistently accounts for most of the variation. 
2 for the main effects of sex were considerably lower than the strain 
main effects, except for left and right adrenal weight measures. However, sex ! 
strain interaction effects were of greater magnitude than the main effects of sex, 
though not as large as strain effects. 
Sub-populations effects 
In our comparison of historical strains with the newly expanded BXD lines 
(BXD Sub-population effects), we evaluated differences among the three groups 
of BXD RI lines tested simultaneously for all 257 measures. These were BXD 1
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32 (208), BXD 33 42 (209) and BXD 43 100 (162). Only the adrenal weight 
measures show any significant differences among the three sub-populations for 
the left (p = 3.23E 04) and right (p = 1.99 E 04) adrenal weights, when sub-
population means are considered. Below we address the issue of mapping in the 
combined sub-populations. 
Comparison of phenotypes across time and environments 
Saline-induced locomotor response  
Locomotor activity in an open field has been commonly used as a 
measure for exploration, novelty seeking, anxiety and predisposition to addiction 
to drugs of abuse. In our study, two laboratories, Memphis (cocaine) and UTHSC 
(ethanol), collected data on open field locomotion following saline in 15 and 20 
min on 64 BXD RI strains, respectively. We compared these data with data 
collected on saline-induced locomotor response by Demarest and colleagues on 
25 BXD RI strains (54). Results indicate that there is good correlation among 
data on saline-induced locomotor response across the three sets (Figure 2-3). 
Correlations among the rMemphis,UTHSC = 0.556, rMemphis,Demarest = 0.781 and 
rDemarest,UTHSC = 0.695. These results confirm previous reports that locomotor 
activity is a highly stable trait and that saline-induced locomotor response is not 
only robust across laboratories but also across previously published studies. 
Thermal nociception  
Sensitivity to thermal stimuli is a complex trait that has been used as a 
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Figure 2-3. Correlation of behavioral measures across environments and 
time.  
(a) Saline-induced locomotor activity is well correlated across test sites 
and time periods. (b) Another measure for which positive correlations existed 
across test sites and time periods is of thermal nociception (from (164)). 
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predictor of sensitivity to analgesic drugs. Thermal nociception (hot plate latency) 
was performed in two laboratories, namely, ORNL and Memphis in this study. 
Data collected in this study were compared with a previously published study of 
thermal nociception by Mogil and colleagues (140) and Brigman and colleagues 
(24) (GeneNetwork RecordID: 10897). Correlations ranged from 0.274 and 0.799 
(Figure 2-3). There is poor correlation among the data collected at the 
Memphisand ORNL laboratories and can likely be attributed to the two different 
hot plate temperatures used. The hot plate test was performed at 52°C at 
Memphis, whereas at ORNL the hot plate temperature was 54°C. Specifically, 
ORNL hot plate data have a slightly higher correlation to the Mogil study 
compared with the Memphis hot plate data. This is likely due to the 54°C that 
was employed in both the ORNL hot plate study and the Mogil study. The range 
of values obtained at ORNL and Memphis was lower than those of the other 
testing laboratories, which produced some range restriction in the observed 
correlation coefficients. This may be due to more consistent laboratory 
environmental conditions in these assays or to experimenter effects on stress-
induced analgesia, both of which have been previously reported to influence 
thermal nociception (37, 38). These correlations are lower than the inter- 
laboratory correlations than those reported by Wahlsten and colleagues (216). 
This may be due to the limited genetic variability in the BXD RI panel relative to a 
survey of the common inbred strains, but could also be due to the lower 
heritability of hot plate measures relative to other measures for which this type of 
analysis has been performed. 
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QTL mapping and genetic correlations 
As an example of a single-trait analysis in the newly expanded strain set, we 
performed an analysis of mechanical nociception, the latency to respond to a 
plastic-coated smooth alligator clip placed on the tail (Figure 2-4). Previous 
studies of this trait in inbred mouse strains show high heritability of 0.69 (115). 
Analysis in MouseTrack using the RI analysis tool showed that this measure has 
statistically significant main effects of sex and strain (Sex: !2 = 0.0029, p < 0.04; 
Strain: !2 = 0.26, p < 0.001), and interaction effects (Sex " Strain: !2 = 0.021, p 
< 0.03,). The variances accounted for by strain are 0.32 and 0.27 in females and 
males, respectively. BXD sub-population effects on females (p < 0.68) and males 
(p < 0.93) were non-significant. Because the main effect of sex was significant, 
male and female data were exported separately for analysis in GeneNetwork, 
which uses a single vector of strain means as input. Permutation thresholds for 
significant and suggestive LOD scores were 3.78 and 2.21, respectively, in males 
and 3.6 and 2.27, respectively, in females. Interval mapping of tail clip latency for 
males of the full BXD RI panel shows suggestive QTL on Chr 2 (LOD = 2.8) and 
9 (LOD = 3.5), whereas suggestive QTL for females of the full panel are located 
on Chr 1 (LOD = 3.5), 11 (LOD = 3.0) and 17 (LOD = 2.5). Genes within the one-
LOD confidence interval from QTL peaks for males (Chr 2: 77–97 Mb; Chr 9: 44–
48 Mb) and females (Chr 1: 90–95 Mb and 97–107 Mb; Chr 11: 53–55 Mb; Chr 
17: 78–84 Mb) were exported as positional candidate gene lists. These results, 
generated in the full RI panel (BXD 1–100) were compared with interval mapping
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Figure 2-4. QTL mapping of tail clip latency in old and recent BXD RI strain 
panels.  
QTL analysis of a single-trait, tail clip latency was performed across three BXD 
panels, namely, Taylor I (BXD 1 32), Recent BXD RI (BXD 33 100) and Full 
BXD RI (BXD 1 100). In females, suggestive QTL were detected on Chr 1 and 9 
for Taylor I (a), Chr 8 for the Recent BXD RI (BXD 33 100) (b) and Chr 1, 11 and 
17 for the Full RI Lines (c). Mapping of tail clip latency in males showed no 
suggestive QTL for Taylor I (d), suggestive QTL on Chr 2, 9 and 18 for Recent 
BXD RI (BXD 33 100) (e), and two suggestive QTL on Chr 2 and 9 for the Full RI 
panel (f) (from (164)). 
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results generated from previously available BXD RI lines including just the 
original set (Taylor I, BXD 1–32), and with exclusive use of the recent RI lines by 
Taylor (Taylor II, BXD 33–42) and by Peirce and colleagues (BXD 43–100). 
Quantitative trait locus mapping for each of the four sets (two male and two 
female sets) was performed. In females, suggestive QTL were detected on Chr 1 
and 9 for Taylor I (Figure 2-4a), and Chr 8 for the recent RI set (Figure 2-4b). 
Mapping of tail clip latency in males showed no suggestive QTL for Taylor I 
(Figure 2-4d) and three suggestive QTL on Chr 2, 9 and 18 for the recent RI set 
(Figure 2-4e). The marker present at the peak of the suggestive QTL for females 
is gnf01.018.340 (Chr 1 at 21.43 Mb). This single nucleotide polymorphism 
(SNP) lies within the Kcnq5 potassium channel gene (KCNQ5) (UCSC genome 
browser, http://genome.ucsc.edu/index.html, July 7, 2009). KCNQ channel 
(K(V)7.2-5) genes have been implicated in neuropathic pain (81). The effect at 
this marker across the Taylor I and recent BXD RI set indicates that while mice 
with the D allele have consistent phenotypic means across both sets, mice with 
the B allele have higher means in the Taylor I lines and lower means in the 
recent lines relative to the D2 allele. However, in the expanded RI set, the D2 
allele is the allele with the higher effect and consequently results in a non-
significant QTL (Figure 2-5). Genetic correlation of tail clip latency to genome-
wide gene expression was performed for each of five brain tissues for which 
expression profiles across the BXD RI lines are in GeneNetwork, namely, whole 
brain, neocortex, striatum, cerebellum and hippocampus. Correlation results from 
each of the five brain regions were filtered using a p value threshold of 0.001 to
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Figure 2-5. Effect plot by BXD RI Strain panel.  
Effect plot of marker gnf01.018.340 (Chr 1at 21.43 MB) in the old (BXD 1 - 
32) and recent BXD RI strain panel (BXD 33 - 100) for tail clip latency in females. 
The marker present at the suggestive QTL in Taylor 1 has a higher phenotypic 
means for the B allele when compared with the D allele. This difference is 
significant and therefore results in the presence of a QTL. The same marker in 
the Recent BXD RI lines has a higher phenotypic mean for the D allele, but no 
QTL is present within this strain set (from (164)). 
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create coexpression candidate lists. All candidate gene lists obtained from 
interval mapping and genetic correlations were then uploaded to 
GeneWeaver.org for combinatorial analysis. Maximum gene to measure 
(phenotype) connectivity was observed for Slfn5 or schlafen 5 (associated with 
positional candidates on Chr 11 for females, male cerebellum gene expression 
correlates and male striatum gene expression correlates) and Ankrd12 or ankyrin 
repeat domain 12 (associated with female cerebellum gene expression 
correlates, male cerebellum gene expression correlates and male hippocampus 
gene expression correlates). Other candidate genes in the interval were not 
found on this list of correlates, but include genes belonging to voltage-gated 
sodium (e.g. Scn2b and Scn4b, Tail Clip-male positional candidates on Chr 4) or 
calcium channels class of genes (13), cholinergic receptors class of genes (e.g. 
Chrm4, Tail Clip-male positional candidates on Chr 2, (63)) and calcitonin 
receptor-like genes or calcitonin gene-related peptides (e.g. Calcrl, Tail Clip Male 
Positional candidates on Chr 2, (120)), all of which have substantial literature 
support for involvement in nociception. 
Multi-trait QTL mapping 
A total of 27 factors accounting for 73% of the total variance for the 234 
variables were obtained using a maximum likelihood factor analysis of behavioral 
traits spanning multiple test batteries. A parallel analysis and an optimal co-
ordinates analysis from the R/nFACTOR package both show eight informative 
factors. The top 15 factors together account for 63.5% of the total variance 
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among the trait measures. Factors accounting for trivial amount of variances 
(<1.3%) have been excluded, as they would contribute little to the overall 
interpretation of the factors. 
Factor interpretations were obtained by examining high and low factor loadings of 
behavioral measures on factors. Significant correlations among factors exist and 
are expected as no factor rotation procedure was applied, as factor rotation 
procedures are often employed to identify distinct factors. Results indicate that 
measures within test batteries load onto multiple factors, thereby supporting the 
hypothesis that each latent factor is associated with multiple behavioral 
measures and each behavioral phenotype measure is determined by variation 
along multiple trait dimensions. Factor 1 has high factor loadings for measures 
almost entirely from the Cocaine test battery and can be interpreted as injection 
stress-induced locomotor activity. Factor 2 represents morphine withdrawal 
measures such as jumps, defecation and urination. Factor 3 represents morphine 
activity/response. Factor 4 represents reactivity measures such as startle 
response and anxiety-like measures. Factor 5 predominantly consists of 
measures pertaining to locomotor activity in a novel environment. Factor 6 
contains measures pertaining to conflict avoidance. Factor 7, like Factor 3, 
consists of measures with high factor loadings pertaining to morphine activity, but 
instead of response these measures are related to duration of activity. Factor 8 
consists of measures related to cocaine sensitization. Factor 9 consists of 
measures related to stress and anxiety such as mechanical sensitivity (von Frey 
threshold) and zero-maze measures and adrenal weights. Factor 10 consists of 
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measures related to vertical activity spanning general behavior and cocaine test 
batteries. Factor 11 represents measures related to startle response. Factor 12 
consists of measures pertaining to drug environment conditioning. Factors 13 
and 14 both consist of responsivity measures, with Factor 13 describing 
response to sensitivity, whereas Factor 14 describes response to novelty. Lastly, 
Factor 15 represents anxiety related to acute stress.  
Quantitative trait locus mapping of these 15 latent factors showed the 
presence of suggestive QTL on Chr 1, 4, 5, 6, 8 9, 10, 11, 13 and significant QTL 
on Chr 9 (Factor 3), Chr 10 (Factor 2) and Chr 13 (Factors 1 and 13) (Table 2-2). 
Results indicate that multiple factors map onto a single chromosome, for 
example, distal Chr 13, has suggestive QTL for Factors 1 (76 86 Mbp), 5 (78 84 
Mbp, 94 98 Mbp), 6 (75 98 Mbp) and 10 (91 98 Mbp) and significant QTL for 
Factors 2 (78 80, 88 92 and 94 98 Mbp) and 13 (75 84 Mbp). Factor 15 also 
maps to Chr 13 but maps to the proximal region rather than the distal region. The 
Chr 13 genomic region that encompasses the above-mentioned QTL spans 23 
Mbp (75 98 Mbp) with a total of 124 genes in the interval. Of these genes ninety-
six are polymorphic, among the compelling candidates is Mctp1 (multiple C2 
domains, transmembrane 1). Interestingly, Mctp1 has previously been reported 
to be strongly associated with bipolar disorder in individuals of European 
ancestry (Scott et al. 2009). The large number of polymorphic genes within Chr 
13 QTL intervals could be one possible explanation for the fact that multiple 
factors map onto the same genomic region. To determine the relationship of 
these factors to a substance use-related phenotype, we correlated the factor 
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Table 2-2. Multi-trait QTL mapping. 
 
   Chromosome 





        3.4*    
2 Morphine Withdrawal    3.2*     4.2**  2.8*  
3 Morphine Activity (Initial/Peak response)   3.0*    4.9** 3.2*     
4 Anxiety/Reactivity  2.9*    4.5**  3.0*     
5 Locomotor response to a novel environment      2.5*   2.7*    
6 Activity (Conflict-Avoidance)     2.3*    3.0*    
7 Morphine (Activity:Duration)              
8 Cocaine Sensitization      2.8*    3.4*   





2.6*   2.7*  2.7*   3.5*    
11 Startle            2.6* 
12 Drug-Environment Conditioning             
13 Responsivity-Sensitivity         5.0**    
14 Response to Novelty 3.0* 2.9*           
15 Anxiety-Acute Stress                 2.8*       
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scores to phenotypic values from a previous study of ethanol self-administration  
(166). This analysis illustrates an approach to determine which dimensions of 
heritable behavioral variation are most related to a specific behavioral phenotype. 
Correlations of alcohol preference to factor scores ranged from |r| = 0.076 to |r| = 
0.674, for Factor 4 for which the correlation was negative such that mice with 
increased startle response and anxiety-like phenotypes had higher alcohol 
preference values and vice-versa. This factor is regulated by a QTL on 
chromosome 9 that contains Scn4b, which is an expression correlate of both 
ethanol withdrawal and Factor 4. 
Combinatorial analysis of gene to phenotype associations 
GeneNetwork analysis of each trait resulted in the generation of over 
3,500 sets of genes that are associated with trait values either via genetic 
correlation of gene expression in one of the five target tissues or through 
positional candidacy in significant or suggestive QTL. These gene phenotype 
associations were integrated via a combinatorial analysis, which represents the 
data as a bi-partite graph consisting of gene vertices and phenotype vertices. 
the gene vertices represent each list member. Edges connecting these vertices 
represent significant gene  phenotype associations. The union of all lists 
contained occurrences of approximately 33,000 genes and ESTs. However, 
many of these genes are represented only once, and through convergent 
analysis can be eliminated. By analyzing the number of phenotypes to which 
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each gene was associated, we were able to identify those genes that most 
broadly and reliably related to the behavioral functions assessed. A ranked 
phenotypes. These rankings were made a part of the NeuroSNP database for 
supplementing addiction arrays (179). The most highly connected gene was 
Mef2c; interestingly this gene also resides in the Chromosome 13 QTL interval 
for several behavioral factors. It should be noted that the composition of the 
behavioral phenotypes in this analysis influences the results obtained. For 
example, some aspects of behavior such as locomotor behavior and anxiety-like 
behaviors have many measures in this study. As such, they are over-weighted 
relative to other aspects of behavior. Despite the overweighting of certain 
measures, we conclude that the most highly connected genes are still broadly 
connected with approximately 150 unique traits. These traits include traits 
measuring anxiety, stress and pain sensitivity and span multiple test batteries 
namely cocaine, general behavior, morphine, ethanol and pain.  
Genes that were highly connected to many of the trait measures were entered 
into gene set over-representation analysis using WebGestalt system, which 
performs a hyper- geometric test for the enrichment of Gene Ontology and 
KEGG pathway annotations among sets of genes. Among the top most highly 
connected 5% of genes, significant over-representation (p < 1E  05) was 
observed in 30 pathways of relevance to brain and behavior. The top most highly 
connected 10% of genes showed significant over- representation (p < 1E  05) of 
32 pathways related to brain and behavior (Table 2-3). These results indicate the 
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Adherens junction  5.42E-08 8.18E-07 
Adipocytokine signaling pathway  4.43E-03 3.38E-09 
Axon guidance  2.74E-11 7.72E-08 
B cell receptor signaling pathway  3.21E-06 1.47E-08 
Calcium signaling pathway  1.02E-09 1.03E-11 
Cell adhesion molecules (CAMs)  9.12E-09 5.02E-05 
Cell cycle  1.67E-09 2.26E-04 
Chronic myeloid leukemia  1.53E-05 4.53E-06 
Colorectal cancer  6.16E-09 6.31E-08 
Cytokine-cytokine receptor interaction  NE 1.05E-07 
Focal adhesion  4.42E-09 4.96E-08 
Gap junction  6.08E-08 4.57E-07 
Huntington's disease  2.09E-07 8.18E-08 
Insulin signaling pathway  8.06E-08 7.15E-08 
Jak-STAT signaling pathway  7.35E-03 1.91E-06 
Leukocyte transendothelial migration  1.38E-05 8.57E-08 
Long-term depression  6.56E-08 7.13E-05 
Long-term potentiation  9.80E-11 1.04E-05 
MAPK signaling pathway  8.66E-15 1.43E-13 
Natural killer cell mediated cytotoxicity  1.07E-07 3.60E-14 
Neuroactive ligand-receptor 
interaction  NE 1.31E-07 
Phosphatidylinositol signaling system  7.27E-06 1.31E-03 
Regulation of actin cytoskeleton  1.13E-12 5.51E-10 
T cell receptor signaling pathway  4.48E-08 9.56E-12 
Tight junction  6.36E-07 1.45E-04 
Toll-like receptor signaling pathway  7.98E-05 1.73E-09 
Wnt signaling pathway  1.07E-15 2.50E-09 
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pathways that are either candidate causes or are under regulation of genetic 1 
polymorphisms that are commonly observed in the BXD population. The principle 2 
behind this approach is that genetic variation affects many genes associated with 3 
QTL candidates, and that the convergent evidence gained from multi- 4 
dimensional analyses of the same traits can highlight the most frequently 5 
associated pathways. Because these data have all been deposited in the 6 
GeneWeaver.org tool, users of these data can perform analyses of specific and 7 
roughly balanced subsets of the traits. 8 
Discussion 9 
BXD RI panels are currently the largest RI strain panel available. In 10 
addition to being the largest, the BXD RI panel have a rich history of use in 11 
behavioral genetics, increased numbers of recombinations and improved 12 
precision in QTL mapping (compared to a F2 or BC mapping population). 13 
However, effective utilization of this resource warrants improvements in 14 
behavioral phenotyping protocols that facilitate rapid, efficient and accurate 15 
phenotypic measurements across large numbers of strains. By taking advantage 16 
of the high-throughput behavioral cores established by the NIMG ENU- 17 
Neuromutagenesis program of the TMGC, we were able to measure over 250 18 
behavioral phenotypes across four sites in the expanded BXD RI strain panel. 19 
These measures were obtained, on average, across 58 BXD RI strains with at 20 
least 10 males and 10 females per strain. 64.61% of these phenotypes have 21 
genetic effect sizes of at least 30% making them amenable to QTL mapping. A 22 
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genetic effect size of 30% with a within-strain sample size of 20, allows us to 1 
detect QTLs where the correlations between the molecular marker and the 2 
behavioral phenotype is approximately 0.97. It should be noted that these 3 
calculations were performed using two assumptions: First, the molecular marker 4 
is directly linked to the QTL and second, only additive QTLs are considered. 5 
Violations of these assumptions will result in lower correlations between the 6 
molecular marker and phenotype, possibly leading to increases in false positives. 7 
Additionally, the sample sizes employed in our study enable us to detect 8 
significant QTLs (p < 0.05) with an effect size of 16% with 90% power. Increasing 9 
the number of strains will help in detecting QTLs with smaller effect sizes. For 10 
example, if one were to utilize the entire BXD RI strain panel (n = 89), one can 11 
map QTLs with an effect size of 11%. Furthermore, if one were to utilize a F2 12 
population to map traits with heritability of 0.30, then the effective sample size 13 
would be approximately 295. This number increases to 760, when the heritability 14 
of the train being mapped is low, around 0.10 (Figure 2-6). It would be extremely 15 
resource and cost intensive (genotyping) to perform QTL mapping population in a 16 
F2 populations with the above mentioned sample sizes. Even if methods such as 17 
selective genotyping are used to abate genotyping costs, this comes with a 18 
decrease in statistical power to detect QTLs.  19 
The majority of the behavioral traits measured had significant main effects 20 




Figure 2-6. Equivalent F2 sample sizes for 58 RI strains for varying n and 2 
h2. 3 
Estimated F2 sample sizes for 58 RI strains as a function of within strain sample 4 
size (n) and heritability (h2). As h2 decreases the equivalent F2 sample size 5 
required increases compared to an RI strain panel, resulting in increased cost 6 
(due to genotyping).  7 
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studies (38, 215). It is important to account for significant strain ! sex interactions 1 
while mapping such traits. In GeneNetwork, this can be achieved by mapping the 2 
two sexes separately (as was done in our study). Another approach is to regress 3 
male data with female data and vice versa followed by single marker correlations 4 
using the resultant regression residuals (70). Both the above-mentioned 5 
approaches decrease the overall statistical power as they involve grouping the 6 
data by sex prior to running the analysis. By employing a nested model that 7 
appropriately accounts for sex across and within strain, better statistical power in 8 
mapping traits can be achieved. However, permuting such a model is complex 9 
due to the resulting non-independence within strains. Permutations 10 
methodologies have been proposed to address such issues (160). In our study, 11 
we found sex differences in trait heritability such that for certain traits female 12 
were higher than males and vice versa. This suggests increased within strain 13 
variance relative to between strain variance. Increased within stain variation is 14 
indicative of additional factors that influence the proportion of phenotypic 15 
variation that is genetic. In males such factors include, social dominance. In 16 
females, studies have revealed the influence of estrous cycle variation in 17 
behavior (14).  Housing density and social isolation due to testing protocols also 18 
introduce additional variation that influences trait heritability (139). 19 
 Since the BXD RI strain panel has gone through two expansions after its 20 
initiation in 1979, we assessed sub-population effects across all traits measured. 21 
Only male adrenal weights had significant sub-population main effects. Since all 22 
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but one trait showed significant sub-populations effects, phenotypically it is safe 1 
to consider all three BXD RI sub-populations as one large BXD RI strain panel. 2 
However, genotype distribution patterns reveal a completely different picture. 3 
Shifman and colleagues (187) detected 52 of 13,367 SNPs wherein the first BXD 4 
RI sub-population showed no variation in their genotype distribution patterns. In 5 
the second BXD RI sub-population, only five of the 52 SNPs show no variation. 6 
All SNPs with fixed SDPs in the first two BXD RI sets show variation in the 7 
expanded BXD RI sub-population. The lack of variation in the SDPs of typed loci 8 
in the first and second sub-population will affect QTL mapping, as these loci will 9 
be non-detectable. Similarly using the entire BXD RI panel without accounting for 10 
sub-population structure could result in varying mapping results.  11 
 Despite the advantages offered by the BXD RI strain panel, it suffers from 12 
certain limitations. First, as it is derived from two progenitor strains, the breeding 13 
design is only able to capture a limited amount of genetic variation 14 
(approximately 16%). Second, centimorgan or sub-centimorgan precision in QTL 15 
mapping is not yet attainable. And lastly, the presence of linkage disequilibrium 16 
could lead to detection of false positive QTLs. Even in the light of these 17 
limitations, the ability to undertake integrative data analysis within the BXD RI 18 
strain panel makes them an ideal resource for the genetic analysis of quantitative 19 
traits. This is primarily due to its role as a genetic reference population. With the 20 
advent of advanced mapping populations, such as the CC, the limitations of RI 21 
panels such as the BXD RI will be alleviated. The CC is an emerging RI panel 22 
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that is being derived from eight phenotypically and genetically diverse founder 1 
strains (34, 42, 95, 142). The initial founder strain diversity facilitates increases in 2 
the total amount of genetic variation captured, numbers of recombination, and 3 
precision and resolution of QTLs. Application of high-throughput behavioral 4 
phenotyping techniques to the CC may help in validating QTL detected in two 5 
progenitor RI strain panels. Furthermore, the increased mapping resolution 6 
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Abstract 15 
Over the last few decades, panels of genetic reference populations (GRP) 16 
have been utilized for the genetic dissection of complex traits. A lot has been 17 
learnt from existing GRP, however they are yet to be utilized to their full potential. 18 
Furthermore, current GRP fail to model complex human diseases due to limited 19 
heterogeneity as a consequence of derivation from two founder strains. The 20 
collaborative cross (CC) is a mouse reference population with high allelic 21 
diversity that is being constructed using a randomized breeding design that 22 
systematically out-crosses eight founder strains, followed by inbreeding to 23 
establish new highly recombinant inbred (RI) strains. Five of the eight founders 24 
are common laboratory strains and three are wild-derived. Since its inception, the 25 
partially inbred CC has been characterized for physiological, morphological and 26 
behavioral traits. The construction of this population provided a unique 27 
opportunity to observe phenotypic variation as new allelic combinations arose 28 
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through inter-crossing and inbreeding to create new stable genetic combinations. 1 
Processes including inbreeding depression and its impact on allelic and 2 
phenotypic diversity were assessed.  Phenotypic variation in the CC breeding 3 
population exceeds that of any existing mouse genetic reference populations due 4 
to both high founder genetic diversity and novel epistatic combinations. However, 5 
some focal evidence of allele purging was detected including a suggestive QTL 6 
for litter size in a location of changing allele frequency. Despite these natural 7 
consequences of inbreeding, high diversity and precision for genetic mapping 8 
remains. These results demonstrate the potential of the CC population, once 9 
completed. 10 
Introduction 11 
Genetic reference populations (GRP) are an invaluable resource for the 12 
study of complex traits. An extremely valuable characteristic of these populations 13 
is their ability to facilitate data integration across multiple phenotypic domains 14 
and biological scales (210). However, currently existing reference populations 15 
are yet to be utilized to their full potential. This is primarily due to the derivation of 16 
existing panels from two founder genomes and limited number of RI strains 17 
available in an analysis. The presence of only two founder strains limits the 18 
amount of genetic variation that can be captured. Additionally, the founder strains 19 
(the classical inbred strains currently used) share large fractions of their 20 
genomes due to identity by descent (IBD), further limiting allelic diversity and 21 
variation. This results in non- - 22 
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QTL mapping (175). These limitations have necessitated the development of new 1 
and advanced GRP. The collaborative cross (CC) is one such emerging 2 
advanced GRP. The CC is derived from eight genetically and phenotypically 3 
diverse inbred founder strains. The eight strains that were selected are  A/J, 4 
C57BL/6J, 129S1/SvImJ, NOD/LtJ, NZO/HlLtJ, CAST/EiJ, PWK/PhJ and 5 
WSB/EiJ. Three of the eight founder strains, namely, CAST/EiJ, PWK/PhJ and 6 
WSB/EiJ are wild-derived strains representing, M. m. castaneus, M. m. musculus 7 
and M. m. domesticus mouse sub-species, respectively. The inclusion of three 8 
wild-derived strains introduces additional genetic diversity and in addition to the 9 
five inbred strains, helps capture approximately 90% of available genetic 10 
variation. In addition to increased genetic variation, the CC is expected to have 11 
higher numbers of recombinations and larger numbers of independent genetically 12 
diverse RI strains than any existing GRP. These features will make the CC a 13 
widely used resource for the genetic analysis of complex human disorders and 14 
diseases. 15 
Breeding design 16 
The breeding scheme employed in the derivation of the CC involves three 17 
generations of out-crossing followed by over 20 generations of inbreeding (Figure 18 
3-1). The first generation of out-crossing (G0) results in 56 G1 (two-way) hybrids. 19 
Pairs of non-overlapping G1 hybrids are then out-crossed to generated four-way 20 
G2 progeny.  Out-crossing pairs of four-way G2 yields an eight-way G2 progeny 21 




Figure 3-1. Collaborative cross breeding design (34). 2 
Breeding design for one eight-way CC RI strain is shown. Letters A-H represent 3 
the eight CC founder strains. Positions of the eight founder strains determine 4 
contributors of mitochondrial DNA and Y chromosome. In above schematic, 5 
strain A contributes the mitochondrial DNA, while strain H contributes the Y 6 
chromosome (from (34)). 7 
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sibling mating for over 20 generations. The overall goal of breeding design 1 
described above is to generate hundreds of independent CC RI strains, each a 2 
fine-grained mosaic of the eight founder strains.  3 
Methods 4 
Subjects 5 
A total of 650 lines were initiated according to the Complex Trait 6 
Consortium protocol (42). Of these, 414 lines with at least one male or one 7 
female survived to the G2:F5 generation, while the remaining lines were lost 8 
during the inbreeding process. Litters were weaned at approximately three weeks 9 
of age, into breeding pairs determined by the CCWORKS software assisted 10 
mating system developed by Kenneth F. Manly (34). Litter size, parental age at 11 
birth of first litter, and length of the interval from mating to the first litter were 12 
recorded as measures of fecundity. Mice were maintained in breeding pairs until 13 
they entered the phenotyping protocol. Retired breeders from the cross 14 
population were phenotyped on a variety of behavioral, physiological and 15 
morphological measures. Phenotyping was performed across generations to 16 
evaluate trait heritability. Phenotyping and genotyping were performed in at least 17 
one breeding pair per line from generation G2:F5-G2:F8 for QTL analysis. Most 18 
of the genotyped mice came from the G2:F5 generation. From this generation, 19 
235 lines were tested. At this generation the population is estimated to be 20 
approximately 75% inbred at the genotyped loci (34), based on allelic identity by 21 
descent calculations performed using the R/ricalc package (25). Because assays 22 
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were added to the phenotyping pipeline throughout the course of the breeding 1 
project not all mice were evaluated on all measures. Approximately 7,500 mice of 2 
both sexes (except for gonadal fat pad mass and testes weight) from up to 626 3 
lines were phenotyped for body weight, tail length, fasting plasma glucose level, 4 
and weights of kidney and heart, behavioral and physiological traits; of these, 5 
approximately 3,000 have been phenotyped for adiposity based on perigonadal 6 
fat pad weight. 7 
Mice did not enter the phenotyping queue until the birth of their grand- 8 
progeny to ensure that lines could be propagated. Average age of testing was 9 
38.5 weeks. Over 95% of the mice were phenotyped between the ages of 20 to 10 
100 weeks. Of the total number of mice phenotyped, 52% were females and 48% 11 
were males. 12 
General phenotyping methods 13 
The phenotyping strategy was designed to capture a panel of complex 14 
traits amenable to high throughput analyses while broadly reflecting behavior, 15 
morphology and physiology. Upon birth of grand-progeny mice were separated 16 
into individual pens for phenotyping. The individuals were then moved to a 17 
holding room where they were housed for three weeks prior to testing where 18 
females were checked to ensure that they were not pregnant at the time of 19 
testing. Mice were housed in this room throughout testing. At the start of the 20 
week prior to the first test an elbow shaped PVC pipe was added to each cage as 21 
a standardized enrichment device. At this point in the queue, mice intended to 22 
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begin testing the following week remained in place on one side of one rack. 1 
Detailed phenotyping and dissection methods are described in detail elsewhere 2 
(165) 3 
Genotyping and SNP selection 4 
A custom array using the Illumina iSelect platform for the Infinium system 5 
was developed for SNP genotyping. A subset of 11,969 SNPs were chosen from 6 
the NIEHS-Perlegen combined SNP panel (232). A sliding window was utilized in 7 
order to search for the minimum sets of SNPs that could discern all eight founder 8 
strains. The search was terminated either when a set of SNPs were identified 9 
that together could discriminate all eight founder haplotypes or the window length 10 
reached 1.86 Mbp. Upon termination a new search window was initiated. The 11 
resulting array enabled genotyping at over 1200 such windows. This algorithm 12 
ensured that for a given number of SNPs on the array, the maximum density of 13 
informative markers could be used, while still ensuring that at any locus, ancestry 14 
can be traced back to one of eight founders.   15 
Data analysis  16 
Statistical analyses were performed within the MouseTrack database 17 
environment (mouse.ornl.gov; (10)), which includes SAS v. 9.1.3 tools for 18 
univariate statistics, univariate and multivariate outlier detection, modeling of litter 19 
size, and calculation of parent-offspring regression coefficients (34). For 20 
modeling of cross type and other effects on litter size and inbreeding depression, 21 
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we employed mixed models with random effects of specific crosses within cross 1 
types.  Heritability for the progenitor generation was estimated using strain 2 
intraclass correlations, and for subsequent generations, it was estimated using 3 
parent-offspring regression by calculating the slope of the regression between 4 
the mid-parent (mean of the two parents) and offspring trait values. We note that 5 
these estimates cannot be extrapolated to heritability defined as transmission of 6 
phenotypic values in wild randomly mating populations. In wild randomly mating 7 
populations it is customary to adjust regression coefficients by relatedness of the 8 
two samples, nor is that our objective. We use unadjusted parent-offspring 9 
relations for the monitoring of resemblance among relatives throughout the 10 
inbreeding process.  For the majority of traits, untransformed data were used to 11 
estimate resemblance of relatives. To more closely reflect genetic contribution to 12 
tissue function rather than allometric relationship to body weight, organ weights 13 
were first adjusted to body weight using a regression model in which individual 14 
trait values were regressed to the population mean. Only data from extant lines in 15 
the terminal generation studied were used to calculate parent-offspring similarity 16 
estimates.  17 
QTL mapping 18 
QTL mapping was undertaken using the R/Happy package developed 19 
based on multipoint HAPPY dynamic-programming algorithm and regression 20 
models (145). Trait data from G2:F5 generations and greater were utilized in the 21 
mapping analysis. Sample sizes ranged from 160 to 293 lines with at most one 22 
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male and/or one female per line. Each trait was assessed for normality prior to its 1 
mapping. Appropriate data transformations were applied to trait data that 2 
deviated significantly from normality. For each trait an additive model genome 3 
scan was preformed. For each marker, R/Happy (145) returns a logP value. 4 
Additionally, for each marker using the residual sums of square under the null 5 
hypothesis of no segregating QTL (RSS0) and alternative hypothesis (RSS1, 6 
additive or full model) LOD scores were calculated using the following equation: 7 
LOD Score = (n/2) * log10(RSS0/RSS1). 8 
This statistic can be utilized to determine significant and/or suggestive 9 
QTLs. Genome-wide significance thresholds were obtained using a modified 10 
permutation algorithm rather than the one available in the R/Happy package. The 11 
R/Happy package treats each observation as an independent observation and 12 
permutes the phenotype between subjects while keeping the genotypes fixed. In 13 
the mapping data utilized in the collaborative cross, we use two subjects per line 14 
(one male and one female). This introduces a dependent relationship among 15 
subjects (sib-pairs). Therefore lines are permuted rather than subjects and sex is 16 
randomized within lines, while keeping the genotypes fixed. One thousand 17 
permutations were performed and permutation based genome-wide thresholds 18 
were used to identify significant (5%, 10%) and suggestive (63%) QTLs. 19 
Confidence intervals around significant and/or suggestive QTL peak was defined 20 
using a 1.5 LOD support interval. Genes within this interval are considered 21 




Phenotypic variation 2 
Phenotypic variance for many traits increased in the G1 generation (Table 3 
3-1) relative to progenitor lines. However, phenotypic variation decreased slightly 4 
in the G2 and beyond.  For all morphometric measures, the distribution of 5 
individual scores showed greater dispersion in the CC lines relative to the 6 
progenitors (Kolmogorov-Smirnov p < .05). As expected from the wide range of 7 
body sizes among the progenitor strains, indicators of overall growth, vary widely 8 
among the CC lines. For example, among progenitors, body weight ranged from 9 
25.56 ± 0.85 g (WSB/EiJ) to 29.66 ± 2.16 g (NZO/HlLtJ), whereas in the 10 
inbreeding generations (G2:F5  G2:F8) this measure ranged from 23.65 g to 11 
32.00 g. Tail length, an index of linear growth, ranged from 67.92 ± 7.98 mm 12 
(PWK/PhJ) to 94 ± 7.94 mm (NOD/LtJ) among the progenitors, whereas it 13 
ranged from 59.04 mm to 112.00 mm among the inbreeding generations Heart 14 
weight and adiposity index also showed considerable variation among the 15 
progenitors and in the CC offspring, but the CC range was within the progenitors. 16 
While it is interesting to note the spread of phenotypic variation relative to 17 
progenitor lines, increased phenotypic variation among offspring is expected due 18 
to transgressive segregation, the random assortment of increasor and decreasor 19 
alleles that were once in a fixed assortment in the progenitor lines.  Therefore, 20 
we assessed phenotypic variation in the CC in contrast to a relatively large and 21 




Table 3-1. Trait heritability and variation in the emerging CC. 1 
 2 
Table 3-1 continued. 
  Gen. G0 G1 G2 G2 G2 G2 G2 G2 G2 G2 G2 
          F1  F2 F3  F4   F5  F6 F7  F8  




nmice 70 240 557 731 1002 950 754 611 403 333 181 
  26.25 33.95 30.8 30.91 31.23 30.49 29.13 27.64 27.92 24.78 24.33 
S.D. 12.21 10.94 5.79 5.65 6.21 6.41 6.05 5.89 6.26 6.91 6.54 
 148.84 119.54 33.41 31.84 38.52 41.08 36.56 34.59 39.19 47.65 42.65 





















C.V. 0.47 0.32 0.19 0.18 0.2 0.21 0.21 0.21 0.22 0.28 0.27 
h2  0.5 NA 0.3 0.36 0.42 0.64 0.56 0.46 0.61 0.59 0.59 
 S.E.  NA NA 0.04 0.06 0.05 0.04 0.05 0.04 0.05 0.07 0.09 




nmice 63 185 313 471 702 717 607 566 367 277 141 
  85.43 96.95 97.33 98.55 97.34 95.85 93.36 91.17 90.99 85.57 85.65 
S.D. 10.73 4.62 5.42 5.56 6.18 6.92 8.41 7.94 8.49 9.81 12.15 
 115.08 21.31 29.3 30.86 38.09 47.83 70.66 62.9 71.94 96.15 147.42 





















C.V. 0.13 0.05 0.06 0.06 0.06 0.07 0.09 0.09 0.09 0.11 0.14 
h2  0 0.55 0.28 0.44 0.58 0.66 0.7 0.72 0.69 0.67 0.72 





Table 3-1 continued. 
  Gen. G0 G1 G2 G2 G2 G2 G2 G2 G2 G2 G2 
          F1  F2 F3  F4   F5  F6 F7  F8  
Trait                         




nmice 58 179 274 371 536 670 605 566 367 277 141 
  0.17 0.19 0.19 0.19 0.21 0.22 0.2 0.19 0.19 0.17 0.16 
S.D. 0.05 0.05 0.06 0.05 0.07 0.06 0.07 0.06 0.06 0.06 0.06 
 0 0 0 0 0 0 0 0 0 0 0 





















C.V. 0.29 0.26 0.32 0.26 0.33 0.27 0.35 0.32 0.32 0.35 0.38 
h2  NA 0.59 0.07 0.2 0.34 0.21 0.34 0.47 0.49 0.29 0.66 
 S.E. NA 0.12 0.09 0.06 0.09 0.05 0.05 0.06 0.06 0.09 0.14 






nmice 23 271 221 202 120 156 273 437 317 185 70 
  1.74 1.57 1.67 1.6 1.62 1.65 1.71 1.7 1.65 1.67 1.62 
S.D. 0.43 0.28 0.33 0.32 0.35 0.43 0.41 0.42 0.41 0.38 0.34 
 0.18 0.08 0.1 0.1 0.12 0.18 0.17 0.17 0.17 0.14 0.11 





















C.V. 0.25 0.18 0.2 0.2 0.22 0.26 0.24 0.25 0.25 0.23 0.21 
h2  NA 0.26 0.02 0.29 0.53 NA 0.38 0.44 0.45 0.45 0.37 
 S.E. NA 0.07 0.1 0.1 0.15 NA 0.12 0.1 0.06 0.08 0.1 
                          




Table 3-1 continued. 
  Gen. G0 G1 G2 G2 G2 G2 G2 G2 G2 G2 G2 
          F1  F2 F3  F4   F5  F6 F7  F8  








  0.52 0.48 0.52 0.62 0.59 0.52 0.52 0.47 0.44 0.46 0.41 
S.D. 1.18 1.05 1 0.88 0.93 0.79 0.8 0.79 0.77 0.68 0.66 
 1.38 1.1 0.99 0.76 0.86 0.61 0.63 0.61 0.59 0.46 0.43 
Range 0 - 7 0 - 8 0 - 10 0 - 9 0 - 10 0 - 6 0 - 6 0 - 8 0 - 5 0 - 3 0 - 4 
C.V. 2.27 2.19 1.92 1.42 1.58 1.52 1.54 1.68 1.75 1.48 1.61 
h2  0.96 0.47 0.04 0.15 0.24 0.32 0.28 0.14 0.4 0.36 NA 
 S.E. 0.17 0.07 0.07 0.05 0.06 0.04 0.05 0.07 0.1 0.18 NA 









nmice NA 173 59 103 83 83 60 134 166 117 56 
  NA 5.31 4.8 5.27 4.29 5.24 5.67 5.25 5.53 5.76 5.28 
S.D. NA 2.85 1.94 3.3 2.65 2.82 3.59 3.17 3.65 3.68 4.25 
 NA 8.1 3.73 10.86 6.99 7.94 12.83 10.05 13.25 13.48 18.04 



















C.V. NA 0.54 0.4 0.63 0.62 0.54 0.63 0.6 0.66 0.64 0.8 
h2  NA 0.15 NA 0.07 0.07 0.49 0.01 0.36 0.22 0.32 0.7 
 S.E. NA 0.09 NA 0.34 0.2 0.34 0.32 0.21 0.24 0.16 0.41 




nmice NA 173 60 107 86 92 65 136 168 120 56 




















Table 3-1 continued. 
  Gen. G0 G1 G2 G2 G2 G2 G2 G2 G2 G2 G2 
          F1  F2 F3  F4   F5  F6 F7  F8  
Trait                         








S.D. NA 480.13 353.66 412.91 469.71 634.68 510.09 489.89 590.29 622.01 801.14 


























































C.V. NA 0.37 0.24 0.29 0.33 0.41 0.39 0.4 0.46 0.5 0.57 
h2  NA 0.08 NA 0.48 0.49 0.4 NA 0.58 0.22 0.58 0.89 




which we have previously reported phenotypic values for diverse behavioral 1 
measures (164) obtained under the same conditions as our collaborative cross 2 
phenotypic data.  Phenotypic values observed in generations G2:F5 and beyond 3 
for thermal nociception, distance travelled in the open field and body length 4 
spanned a far greater range than those obtained in the BXD RI strain panel 5 
(Figure 3-2).  6 
Analysis of inbreeding depression 7 
During the generation of the CC, we were able to assess the impact of 8 
inbreeding in the emerging CC population using the measure of litter size in 9 
these mice, as previous studies have shown that litter size reflects the impact of 10 
inbreeding depression in mouse populations (88, 91). Among the G1 crosses, 11 
mean litter size was lower for crosses involving one or two wild-derived lines 12 
(Fcross type (2, 51)  = 6.07; p < 0.0043). The pattern of mean differences reveals out- 13 
crossing depression in litter size for some crosses. As previously reported, 14 
NZO/HlLtJ x PWK/PhJ and NZO/HlLtJ x CAST/EiJ matings were avoided due to 15 
exceedingly poor mating performance, and PWK/PhJ x 129/SvImJ gave rise to 16 
infertile males (34).  The mean litter size in the crosses was lower than both 17 
parental means for the 129/SvImJ x NZO/HlLtJ, but not for the reciprocal 18 
NZO/HlLtJ x 129/SvImJ cross. The mean litter size was between the two 19 
progenitors for C57BL6/J x WSB/EiJ and its reciprocal, 129/SvImJ x PWK/PhJ 20 
and its reciprocal, CAST/EiJ x NOD/HlLtJ, WSB/EiJ x A/J and WSB/EiJ 21 




Figure 3-2. Trait variation in the CC compared to the BXD. 2 
Shaded bars represent the phenotypic distribution of the BXD population (A) 3 
Distribution of thermal nociception across the CC and BXD populations. (B) 4 
Distribution of distance travelled in the open field across the CC (during the first 3 5 
minutes) and BXD populations (during the first 5 minutes). (C) Distribution of 6 




common laboratory strains, an increase in litter size was observed. 1 
Among the G2 crosses, patterns of both depression and heterosis were 2 
again observed. G2 mean litter sizes were compared to G1 litter sizes for each of 3 
576 four-way crosses (G1 x G1). Among these, 19 exhibited decreased litter size 4 
indicative of depression, 330 exhibited heterosis, and the remainder fell between 5 
their G1 parental means. All four-way crosses in the G2 generation were 6 
classified into 15 configurations based on whether the parents were offspring of 7 
common x common, common x wild-derived, or wild-derived x wild-derived 8 
strains.  Analysis of change in litter sizes (!LS) from G1 to G2 reveal significant 9 
effects of configuration (F (15,561) = 3.00; p < 0.0002) and number of wild- 10 
derived lines in the four-way cross (F (3,572) = 7.39; p < 0.0001). With increasing 11 
numbers of wild-derived lines among the four grandparents, !LS is increasingly 12 
positive (!0LS  < !1LS < !2LS  < !3LS). 13 
Effects of genetic composition are dependent on the direction of the cross. 14 
When the common x common derived parent is female, the change in litter size 15 
from the previous generation is lower than for all other configurations (F (1,561) = 16 
6.29; p < 0.012), and the litter size itself is higher. As a further test of the 17 
directionality of mating effects, we directly compared each comparable cross of 18 
common x common derived males or females to other configurations (e.g., 19 
[(common x common) x (wild x common)] vs. [(common x wild) x (common x 20 
common)] which revealed significant effects only for the difference between CC x 21 
WW and WW x CC crosses such that wild derived males resulted in an increase 22 
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in litter size when crossed to a common background than do wild-derived 1 
females (F (1,561) = 6.29; p < 0.012). This was tested again by comparing the 2 
effect of crossing wild-derived males to that of common-derived males into 3 
common derived females, which again reveals a greater increase in litter size 4 
when the male is wild-derived (F (1,561) = 5.04 p < 0.025).  5 
Fecundity and reproductive fitness among the advanced inbreeding lines 6 
typically varied outside the range of progenitors. Dispersion of CC fertility related 7 
phenotypes, obtained from G2:F5 and subsequent generations, exceeds the 8 
inbred progenitors for measures including mean litter size, parental age at first 9 
litter, and interval from mating to first litter (Kolmogorov-Smirnov p < .05). 10 
However, litter sizes in these lines cover a smaller range than the G2:F1 11 
population (Figure 3-3). The shrinking range was unilateral such that the 12 
maximum litter size obtained among the lines in inbreeding generations was 13 
successively lower than that observed in the G2:F1, a phenomenon considered 14 
consistent with over-dominance related inbreeding depression. 15 
Intercrossing, inbreeding and their effect on allele frequencies 16 
Lines from G2:F1 and G2:F7 were genotyped to track changes in allele 17 
frequencies across generations. Progenitor alleles entered the population at a 18 
minimum minor allele frequency (MAF) of 0.125 for all autosomal locations and it 19 
is expected that allele frequencies remain stable throughout each generation and 20 
genome location. Efforts were made to balance alleles on the sex chromosomes 21 




Figure 3-3. Litter size and inbreeding depression. 2 
As a consequence of inbreeding, litter size diminishes at each successive 3 
generation of inbreeding. This reflects the phenomena of over-dominance as a 4 




dependent on the position of the progenitor strains in each line’s mating scheme 1 
and were adjusted accordingly. Distribution of strain specific alleles (MAF = 2 
0.125) grouped by progenitor strain of origin indicates that there is no statistically 3 
significant deviation from expectation for the MAF at the majority of these loci 4 
using a !2 test for goodness of fit with a family-wise false discovery rate of 0.05. 5 
Only 95 strain-specific genotyped SNPs showed significant deviations when 6 
comparing progenitor allele frequencies to those of G2:F1 allele frequencies. 7 
Sixty-two were from PWK/PhJ, 15 of these were located on Chr 16 and 22 of 8 
which were on Chr X. Another 21 of these 95 loci were from CAST/EiJ, 18 were 9 
on Chr X. The remaining loci originated from WSB/EiJ (8 loci), A/J (1 locus), and 10 
C57BL/6J (3 loci). Genotyped loci from the three other progenitor strains, 11 
namely, 129S1/SvImJ, NZO/HlLtJ and NOD/LtJ showed no significant deviation 12 
from expected segregation patterns. Comparison of G2:F1 strain specific alleles 13 
relative to those of G2:F7 resulted in only 13 loci with significant deviations from 14 
expected frequencies. Nine of these loci were from PWK/PhJ while the remaining 15 
four loci were from CAST/EiJ. Twelve loci show declining allele frequencies 16 
throughout both out-crossing and inbreeding. Of these, eight loci were from to 17 
PWK/PhJ and four were from CAST/EiJ. The strain specific allele distributions 18 
spread from G2:F1 to G2:F7 indicating that overall alleles at some loci increase 19 
in frequency while other alleles decrease in frequency through the process of 20 
inbreeding (Figure 3-4). A comparison of observed local allele frequencies 21 





Figure 3-4. Changes in minor allele frequencies (MAF) due to inbreeding. 3 
Strain specific MAF in the G2:F1 (A) generation depicts less variation than the 4 
G2:F7 (B) generation, with some spread of allele frequencies evident in the 5 
G2:F7 generation. Allele frequency distributions become asymmetrical for some 6 
strains. The distribution becomes right skewed PWK/PhJ indicating more loss 7 




generations reveals that this increase in variance occurs on a genome wide level 1 
(Figure 3-5). In general, observed changes in allele frequencies relative to 2 
expected frequencies were less pronounced following out-crossing (Figure 3-5A) 3 
than during inbreeding (Figure 3-5B). 4 
QTL mapping in the CC 5 
A total of 102 reproductive, behavioral, physiological and morphological 6 
traits were subject to QTL mapping, though several of the measures were highly 7 
correlated, including 50 sleep related parameters and several similar blood 8 
measures. Approximately 72 unique, though not statistically independent 9 
phenotypes were considered. Among these, eight statistically significant (p < 10 
0.05, Table 3-2) main effect QTLs were detected, including red cell distribution 11 
width, hotplate latency, average percent of sleep time in the dark, distance 12 
traveled in open field during the first three minutes, periosteal circumference of 13 
the femur, and peak activity onset after sleep deprivation, body length and 14 
cumulative distance from the center of the open field (Figure 3-6). An additional 15 
nine suggestive QTL were detected (p < 0.10, Table 3-2).  Confidence intervals 16 
around the significant QTL peaks, estimated using 1.5-LOD drop-off, had an 17 
average width of 3.98 Mb and contained an average of 50 genes each, with 18 
fewer than 10 candidate coding genes for three of the traits. The narrowest 1.5 19 
LOD drop interval detected is 530 Kbp for Peak activity time in hours from activity 20 
onset after sleep deprivation (Chr 9: 29.70 - 30.03 Mbp Build 36 between 21 




Figure 3-5. Allele loss and inbreeding. 2 
Comparison of the percent allele loss between (A) progenitors (G0) and final out-cross 3 
generation (G2:F1). (B) G2:F1 and the seventh inbreeding generation (G2:F7). Positive 4 
values indicate SNPs with an increase in minor allele frequency, while negative values 5 
indicate a decrease (allele loss) in minor allele frequency. The y-axis indicates % change 6 




Figure 3-6. QTL mapping in the CC. 2 
(A) Red blood cell width distribution. (B) Periosteal circumference. (C) Peak activity time 3 
in hours from dark onset after sleep deprivation. (D) Average percentage of sleep time 4 
over dark cycles for all baseline days. (E) Average minimum distance of the center of the 5 
mouse from the absolute center of the open field (cm). (F) Thermal nociception. (G) 6 
Open field locomotion in the first three minutes. (H) Body length. Horizontal lines indicate 7 
genome-wide significance thresholds based on 1,000 permutations. Dotted lines are 8 
genome-wide significant thresholds at p dashed lines indicate genome-wide 9 




Table 3-2. Genome-wide significant and suggestive QTLs, effect sizes and allele effects. 1 
 2 
Table 3-2 continued.                 














Body length 2 rs27338024 
152.9-




± 0.96 -1.63 
A/J 106.61 ± 1.07 0.37 
C57BL6/J 104.20 ± 0.97 -2.04 
CAST/EiJ 106.53 ± 1.02 0.29 
NOD/LtJ 106.22 ± 0.98 -0.02 
WSB/EiJ 112.20 ± 1.25 5.96 
NZO/HlLtJ 106.80 ± 1.13 0.56 
PWK/PhJ 105.30 ± 1.01 -0.95 
                    
Average 
percent 7 rs6381934 
90.9-
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± 1.45 -3.42 
C57BL6/J 25.24 ± 1.18 0.84 
CAST/EiJ 24.55 ± 1.13 0.15 
NOD/LtJ 22.06 ± 1.23 -2.34 
WSB/EiJ 27.27 ± 1.61 2.87 
NZO/HlLtJ 27.12 ± 1.76 2.72 
PWK/PhJ 20.84 ± 1.27 -3.56 











A/J 1.63 ± 0.05 -0.01 
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CAST/EiJ 1.64 ± 0.05 0 
NOD/LtJ 1.54 ± 0.05 -0.1 
WSB/EiJ 1.60 ± 0.05 -0.04 
NZO/HlLtJ 1.59 ± 0.04 -0.05 
PWK/PhJ 1.88 ± 0.05 0.24 










± 0.20 -0.34 
A/J 13.69 ± 0.24 -0.38 
C57BL6/J 14.85 ± 0.18 0.78 
CAST/EiJ 13.64 ± 0.17 -0.43 
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WSB/EiJ 13.20 ± 0.26 -0.87 
NZO/HlLtJ 15.00 ± 0.25 0.93 
PWK/PhJ 13.39 ± 0.20 -0.68 











A/J 0.46 ± 0.69 -1.5 
C57BL6/J 1.15 ± 0.70 -0.81 
CAST/EiJ -2.04 ± 1.01 -4.00 
NOD/LtJ 1.49 ± 0.82 -0.47 
WSB/EiJ 2.19 ± 0.72 0.23 
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PWK/PhJ 3.68 ± 0.62 1.72 
                    
Open field 
locomotion 
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A/J 7.50 ± 0.64 1.9 
C57BL6/J 4.86 ± 0.50 -0.74 
CAST/EiJ 5.21 ± 0.57 -0.39 
NOD/LtJ 8.52 ± 0.75 2.92 
WSB/EiJ 5.01 ± 0.43 -0.59 
NZO/HlLtJ 5.98 ± 0.68 0.38 
PWK/PhJ 4.31 ± 0.59 -1.29 
                    
Periosteal 
circumferen 19 rs6287522 
21.5-
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A/J 4.85 ± 0.07 -0.02 
C57BL6/J 4.95 ± 0.06 0.07 
CAST/EiJ 4.78 ± 0.08 -0.09 
NOD/LtJ 4.66 ± 0.07 -0.21 
WSB/EiJ 5.16 ± 0.08 0.29 
NZO/HlLtJ 5.14 ± 0.09 0.27 
PWK/PhJ 4.78 ± 0.09 -0.1 
SUGGESTIVE QTLS 





A/J 5.01 ± 0.39 0.56 
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CAST/EiJ 3.80 ± 0.32 -0.64 
NOD/LtJ 3.93 ± 0.34 -0.52 
WSB/EiJ 3.61 ± 0.26 -0.83 
NZO/HlLtJ 2.79 ± 0.34 -1.65 
PWK/PhJ 4.66 ± 0.31 0.21 
                    
Gonadal fat 









A/J 0.58 ± 0.08 0.09 
C57BL6/J 0.60 ± 0.07 0.07 
CAST/EiJ 0.82 ± 0.10 -0.15 
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WSB/EiJ 0.47 ± 0.09 0.2 
NZO/HlLtJ 0.62 ± 0.06 0.04 
PWK/PhJ 0.98 ± 0.07 -0.32 
                    
Body weight 2 rs27338024 
154.0-




± 0.57 -0.67 
A/J 27.39 ± 0.72 -0.13 
C57BL6/J 25.72 ± 0.62 1.55 
CAST/EiJ 33.22 ± 2.97 -5.96 
NOD/LtJ 26.30 ± 0.86 0.97 
WSB/EiJ 24.99 ± 0.74 2.28 
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PWK/PhJ 28.97 ± 0.58 -1.7 
                    





A/J 0.42 ± 0.01 -0.01 
C57BL6/J 0.44 ± 0.01 0.01 
CAST/EiJ 0.42 ± 0.01 -0.01 
NOD/LtJ 0.44 ± 0.01 0.01 
WSB/EiJ 0.45 ± 0.01 0.02 
NZO/HlLtJ 0.39 ± 0.01 -0.04 
PWK/PhJ 0.43 ± 0.01 0.01 
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A/J 26.42 ± 2.77 -6.15 
C57BL6/J 31.07 ± 2.77 -1.5 
CAST/EiJ 27.61 ± 2.27 -4.97 
NOD/LtJ 37.13 ± 2.46 4.56 
WSB/EiJ 35.52 ± 2.36 2.95 
NZO/HlLtJ 25.24 ± 3.18 -7.33 
PWK/PhJ 26.16 ± 2.77 -6.41 








± 0.19 -0.16 
A/J 11.14 ± 0.22 0.9 
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CAST/EiJ 10.21 ± 0.23 -0.02 
NOD/LtJ 9.60 ± 0.28 -0.63 
WSB/EiJ 9.91 ± 0.21 -0.33 
NZO/HlLtJ 10.61 ± 0.26 0.38 
PWK/PhJ 10.11 ± 0.28 -0.12 










± 1.13 10.96 
A/J 10.27 ± 1.16 10.27 
C57BL6/J 12.10 ± 0.85 12.1 
CAST/EiJ 14.72 ± 0.91 14.72 
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WSB/EiJ 8.86 ± 0.91 8.86 
NZO/HlLtJ 10.42 ± 1.24 10.42 
PWK/PhJ 9.95 ± 1.05 9.95 










± 0.49 2.24 
A/J 46.36 ± 0.76 -0.02 
C57BL6/J 47.05 ± 0.64 0.67 
CAST/EiJ 45.44 ± 0.43 -0.93 
NOD/LtJ 47.31 ± 0.47 0.93 
WSB/EiJ 46.45 ± 0.46 0.07 
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PWK/PhJ 44.50 ± 0.52 -1.88 










± 0.13 -0.08 
A/J 15.48 ± 0.12 0.03 
C57BL6/J 15.73 ± 0.14 0.28 
CAST/EiJ 15.60 ± 0.16 0.15 
NOD/LtJ 15.69 ± 0.13 0.24 
WSB/EiJ 15.55 ± 0.11 0.1 
NZO/HlLtJ 14.96 ± 0.19 -0.49 




microRNA and two genes  Ntm (neurotrimin) and Snx19. The largest interval 1 
detected for a statistically significant locus was 6.96 Mbp for red blood cell 2 
distribution width containing 232 positional candidate genes.  3 
Periosteal circumference was mapped to a 1.5-LOD interval from 21.55 - 4 
22.51 Mbp on Chr19 (Build 36), containing five candidate genes, including 5 
Tmem2 and Trpm3. For thermal nociception, the 1.5-LOD drop interval (Chr5: 6 
45.44  60.99 Mbp) around the peak marker contains just six genes, Slit2, 7 
Pacrgl, Gpr125, Dhx15, Sod3 and Kcnip4. The 1.5-LOD drop interval for average 8 
minimum distance from the center of the open-field (Chr6, 89.59  93.20 Mbp), 9 
average percentage of sleep time over dark cycles for all baseline days (Chr7, 10 
90.92  96.94 Mbp) and red cell distribution width (Chr7: 105.55-112.52 Mbp) 11 
respectively map onto gene-rich genomic regions with 45, 39 and 221 genes, the 12 
latter containing a cluster of 130 Olfr family members in addition to three 13 
compelling functional candidates, hemoglobins Hbb-b1, Hbb-bh1 and Hbb-y.  14 
We also mapped litter size to identify potential loci that could influence 15 
litter size thereby reflecting inbreeding depression. A suggestive QTL was found 16 
on Chr 6 for the regulation of litter size. This locus harbors several genes for 17 
which alleles have been annotated to embryonic lethality. At this locus, A/J 18 
alleles are associated with higher litter sizes, and NZO with lower litter sizes. 19 
Interestingly, these alleles have significant decrease in frequency (rs13478994, p 20 
< .003; rs29829339, p < .02), suggesting that for any surviving line with an A/J 21 
allele at this location, litter size is elevated.  22 
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Significant QTLs for some traits are the effect of alleles from single strains, 1 
while for other traits the effect is due to alleles present among multiple strains 2 
(Table 3-2). For body length, individuals with alleles originating from WSB/EiJ at 3 
the QTL were significantly different from individuals with alleles derived from 4 
other strains. The QTL for hot plate thermal nociception was driven by significant 5 
differences among individuals with alleles derived from PWK/PhJ and relative to 6 
those with other alleles except for C57BL6/J.  For gonadal fat pad mass, alleles 7 
specific to PWK/PhJ were significantly different from others alleles except for 8 
CAST/EiJ and 12S1/SvImJ. For peak activity onset after sleep deprivation, wild- 9 
derived strains PWK/PhJ and CAST/EiJ differ significantly from WSB/EiJ, 10 
CAST/EiJ is significantly different from 129S1/SvImJ, PWK/PhJ is significantly 11 
different from A/J and A/J is significantly different from 129SvImJ. For other 12 
measures, a more complex pattern of strain-specific effects emerges (Table 3-2). 13 
A composite interval mapping approach enabled the detection of additional loci 14 
for several phenotypes (Table 3-3). For example, a search for additional QTLs for 15 
open field locomotor behavior, conditioned on the Chr 4 locus reveals an 16 
additional locus on Chr 9 at rs33324954, from 108  113 Mbp, consistent with 17 
previously reported QTL for this phenotype (90). 18 
Discussion 19 
The need for advanced GRPs stems from the inherent drawbacks that 20 
plague existing GRPs. These drawbacks include limited genetic variation and 21 
limited numbers of strains, which ultimately makes the task of QTL detection and 22 
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Table 3-3. Additional loci detected using composite interval mapping. 1 
 2 
Table 3-3 continued.       
Trait Original QTL 
Second 







length Chr 2 Chr 13 rs6216118 99.3 
75.23 - 
101.45 7.15 
              
Body 
weight Chr 2 Chr 8 rs31787744 66.88 
60.82 - 
87.93 7.28 
              
Brain 
weight 
Chr 7 Chr 17 rs33558716 56.63 55.67 - 64.91 9.3 
  Chr 1 rs6263216 177.76 173.30 - 182.73 8.94 
  Chr 13 rs29513935 31.59 30.66 - 34.12 9.23 
              
Eosonophil 
% 
Chr 17 Chr 4 rs27479104 118.79 103.41 - 155.32 7.24 
  Chr 19 rs30748908 57.83 57.34 - 61.14 6.68 




Chr 8 Chr 9 rs6387702 46.82 38.47 - 41.22 6.83 
         43.20 - 50.56   
        106.92 - 107.62   
              
Hot plate 
latency Chr 5 Chr 18 rs6203819 52.98 
50.29 - 
55.21 8.69 
              
Monocytes 
% Chr 17 Chr 2 rs27184231 23.43 
22.07 - 
25.32 9.51 
          32.12 - 34.11   
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Table 3-3 continued.       
Trait Original QTL 
Second 











center         
42.48 - 
47.45   
!!   Chr 16 rs37822351 21.37 14.19 - 30.95 8.11 
              
Open field 
locomotion Chr 4 Chr 9 rs33324954 111.42 
108.93 - 
113.57 7.77 




Chr 7 Chr 1 rs51956473 146.34 136.71 - 155.81 7.14 
  Chr 8 rs6304230 119.88 119.09 - 124.88 6.44 
              




Chr 7 Chr 2 rs6226117 178.88 171.36 - 178.97 12.38 
              
Tail clip 
latency 
Chr 2 Chr 5 rs32966653 56.15 53.92 - 65.37 8.42 
        72.53 - 75.66   
        76.14 - 79.62   
  Chr 15 rs33196993 37.34 11.60 - 12.27 7.55 
        12.73 - 23.44   
        25.53 - 27.34   
        30.13 - 51.60   
              
Periosteal 
circ 
Chr 19 Chr 13 rs46919382 19.04 4.68 - 6.92 9.68 
        18.92 - 20.95   
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candidate gene identification extremely labor intensive. The availability of 1 
advanced, large and diverse panels of GRPs will help alleviate these drawbacks, 2 
while at the same time serving as an invaluable resource to the biomedical 3 
research community. The collaborative cross (CC) is one such advanced GRP 4 
for mouse genetics. Similar panels have either been or are being developed 5 
across multiple species, including D. melanogaster (9), A. thaliana (108), Z. Mays 6 
(29) and C. elegans (99, 122, 176)  7 
The completed CC RI strain panel is expected to have increased numbers 8 
of recombination and smaller haplotype blocks resulting in a fine-grained mosaic 9 
of the eight founder strains. Simulations performed by Karl Broman (25) have 10 
supported this expectation by showing that on average, eight-way RILs have 134 11 
recombinant haplotype blocks compared to 85 in two-way RILs. As expected, the 12 
median lengths of these haplotype blocks are smaller in eight-way RILs (8.5 cM) 13 
compared to two-way RILs (12.9 cM). Comparing the emerging CC populations 14 
(pre-CC) to the above-simulated CC population has been revealed 6% more 15 
detectable recombination breakpoints and smaller median block or segment 16 
lengths (8). Additional simulations, performed by Valdar and colleagues (213), 17 
have assessed the power and precision with which one can map QTL in the CC. 18 
In an extensive series of simulations with several assumptions, Valdar and 19 
colleagues has shown that a QTL with 5% effect size can be mapped with 20 
moderate power (0.67) and high precision (mean location error of 1.14 cM) when 21 
employing 500 RILs. QTL analysis in the emerging CC reveals that with sample 22 
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size of approximately 250 lines with only one or two mice per line, it is possible to 1 
map genetic loci with high precision and moderate to large effect sizes. Among 2 
the significant loci detected, QTL effect sizes ranged from (6.7% to 26%), while 3 
the average 1.5 LOD support interval ranged from (530 Kb to 6.96 Mb) (Table 3- 4 
3). In several instances, the emerging CC had sufficient mapping resolution to 5 
identify one or a few candidate genes. Mapping of activity after sleep deprivation 6 
revealed only three positional candidates, a microRNA and two genes, Ntm 7 
(neurotrimin), which encodes a neural cell adhesion molecule that plays a role in 8 
brain development (31) and Snx19. Allelic variation in neurotrimin could affect 9 
sleep, wake and activity by influencing developmental patterns in central nervous 10 
system structure or through dynamic effects on adult neuronal functions. Sleep 11 
deprivation maximizes the magnitude of slow-wave activity (SWA), which is 12 
directly proportional to the duration of prior periods of wakefulness (6). Increasing 13 
evidence suggests a functional role for sleep and high SWA in synaptic plasticity 14 
(86, 110). Periosteal circumference at the mid-shaft of the femur mapped to five 15 
candidates, Gda, 1110059E24Rik, Tmem2, and Trpm3, a transient receptor 16 
potential channel gene. Periosteal circumference is one of many measures for 17 
skeletal size and is correlated with total body size and total skeletal size, 18 
therefore the gene underlying this QTL could be responsible for global effects on 19 
body size. Mechanistic analysis of the causative locus is the best method to 20 
interpret the specificity of these effects. Neither 1110059E24Rik nor Fam108b 21 
appear to be expressed in osteoblasts or osteoclasts. The Tmem2 gene is highly 22 
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expressed in primary osteoblasts, but the function of this gene in bone biology is 1 
unknown.  The Gda gene appears to be moderately expressed in osteoclasts, 2 
but like Tmem2, the function of this gene in bone biology has not been previously 3 
determined. Expression of Trpm3 has been demonstrated in human osteoblast- 4 
like cell lines and other genes in this family have a known role in osteoblast 5 
differentiation (4). In addition to increased recombinations, improved QTL 6 
mapping power and resolution evident in the emerging CC, the out-crossing and 7 
inbreeding process has had minimal effect on founder strain contribution. 8 
Founder strains entered the populations at a minor allele frequency of 0.125 and 9 
a genome-wide analysis in the emerging CC has revealed equal founder strain 10 
contribution at all loci. This is important since this ensures that the breeding 11 
scheme is truly randomized, balanced and that no single founder strain was 12 
being selected for or against. 13 
Genetic analysis in the emerging CC provides valuable insights in to what 14 
is to be expected from the completed CC. The ability to have large numbers of 15 
independent, phenotypically and genotypically diverse CC RILs will facilitate high 16 
precision QTL mapping and subsequent QTG discovery. Furthermore, the high 17 
amount of genetic variation captured in the CC will make it a better suited to 18 
model complex human disorders thereby facilitating translation research. 19 
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CHAPTER IV: INTEGRATIVE FUNCTIONAL GENOMICS AND QTG 
IDENTIFICATION 
Abstract 
Despite the high heritability of addiction, relatively few underlying genes or 
quantitative trait genes (QTG) have been identified. Recent studies have used 
the integration and convergence of evidence among functional genomics studies 
as a successful strategy towards the efficient and rapid nomination of QTGs. 
GeneWeaver (www.geneweaver.org) is a web resource that facilitates integrative 
functional genomic analyses by providing comprehensive data sources and 
analytical tools. While GeneWeaver facilitates a multitude of genomic analysis, 
one specific application of it is the identification and prioritization of QTGs. Here, 
we apply this web resource towards the identification a highly likely QTG for 
cocaine-induced locomotor activation. Cocaine-induced locomotor activation was 
previously mapped in the recently expanded panel of BXD RI strains to a region 
on Chr 4 and Chr 15, with over 100 and over 70 positional candidate genes in 
their respective 1.5 LOD drop support intervals. Combinatorial analysis using 
GeneWeaver resulted in the identification of Rab3b, based on the following its 
co-occurrence with previously published QTL mapping studies of cocaine related 
behaviors, methamphetamine related climbing and cocaine and amphetamine 
regulated transcript (CART) abundance; convergent evidence from other 
substances of abuse; polymorphisms albeit upstream and intronic; and 
expression pattern in reward pathways. Preliminary functional evaluation of Rab3 
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complex in cocaine response was performed using mixed background Rab3bcd 
triple null mice (B6;129 Rab3bcd-/-). Rab3bcd-/- mice have increased cocaine-
induced activation compared to Rab3bcd+/- and C57BL/6J mice, further 
implicating Rab3b in acute cocaine response. In conclusion, integrative functional 
genomics, performed here within the framework of GeneWeaver, facilitates 
efficient in silico reduction of a QTL interval with numerous positional candidate 
genes to a handful of testable candidate QTGs. 
Introduction 
Advances in genotyping and phenotyping technologies have led to 
mapping of complex traits at an ever-increasing pace across multiple species. To 
date, over 4,600 published mouse Quantitative Trait Loci (QTL) exist, of which 
less than one percent have been successfully identified at the gene and/or 
mutation level. Of these 4,600 QTL, approximately 250 are alcoholism and 
addiction related. Among all the published QTLs, only 20 genes have been 
accepted as QTG (138). The rate-limiting step in the identification of QTGs is not 
in QTL mapping but rather in the identification of the causative variant and 
validation of a gene(s) as the QTG. As shown in Chapters II and III , QTL 
confidence intervals are influenced by a number of factors, including the mapping 
population, sample sizes and trait heritability. This results in a large number of 
positional candidate genes within the QTL confidence interval, making the task of 
gene identification formidable. The emergence of advanced mapping panels, 
such as the collaborative cross (CC) and the diversity outbred (DO), will help 
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achieve greater precision in QTL mapping. However, even in these advanced 
mapping populations, gene level resolution using QTL mapping is still not 
attainable for most traits, requiring the utilization of multiple approaches for the 
identification of causal loci and the nominations of QTGs. 
The QTL to QTG approaches that have been proposed to date can be 
categorized as genetic and bioinformatic approaches. Genetic approaches 
facilitate QTG identification by fine-mapping of the original QTL by taking 
advantage of meiotic recombination. Strategies falling in this category include 
chromosome substitution strains, congenic strain pairs, interval specific 
congenics and fine mapping using advanced intercross lines (AIL) or 
heterogeneous stock (HS), recombinant inbred segregation test (RIST) and Yin-
Yang crosses (50, 74, 188). Genetic approaches often take years and large 
numbers of resources to fine map and confirm QTLs. For example, in a BXD 
recombinant inbred (RI) strain panel of 100 strains, mapping resolution or the 
95% confidence interval (CI) of a QTL with a 5% effect size is approximately 7 
cM (74, 213). A 7 cM interval corresponds to approximately a 14 Mb genomic 
region. Given the average gene density of 10 genes per Mb in the mouse, one is 
still left with approximately 140 positional or QTL candidate genes for further 
validation. This problem is alleviated to a certain extent in the CC mapping 
population. QTL mapping results in the emerging CC population have been 
promising. The average 1.5 LOD support interval was 4.80 Mb with 
approximately 50 positional candidate genes (165). While 50 is a considerable 
 
 110 
reduction from 140 positional candidate genes, the necessity of additional fine 
mapping remains. Using only genetic approaches one could easily take six or 
more years to fine-map and identify the QTG (74). In an attempt to accelerate 
QTG identification, complementary bioinformatic approaches have been 
proposed, including comparative genomics, combined cross analysis and 
sequence and expression analysis (57). These approaches help facilitate the in 
silico reduction of a QTL interval and the identification of highly likely QTGs via 
the use of publicly available genotypes and expression databases.  
Examples of successful identification of QTGs related to addiction using 
genetic approaches include Mpdz (189) and Kcnj9 (109). In these and all QTGs 
identified to date, a stepwise process was utilized in an effort to eliminate all 
other possibilities. The process involved fine mapping, comparing sequence and 
expression levels of genes across the progenitor strains, and in vivo 
confirmation. Bioinformatic approaches on the other hand, although meant to 
accelerate QTG identification, have yet to catch up with the large numbers of 
unresolved QTL. Whether one uses purely genetic approaches or combines 
genetic and bioinformatic approaches for the identification of QTGs, integration 
among diverse genomic data sets is often performed. Furthermore, translating 
findings from mouse to human populations is of utmost importance, so as to 
achieve additional progress in understanding complex human disorders.  
The strategy of integrative functional genomics, complementary to genetic 
and bioinformatics approaches, has been successfully applied towards the 
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nomination of highly likely candidate genes for alcoholism, bipolar disorder and 
drug addiction (117). However, existing integrative functional genomics 
methodologies are tailored towards the needs of a specific laboratory and lack 
computationally efficient infrastructure in the form of databases, algorithms and 
user interface that facilitates genome scale integrative analyses in a seamless 
and scalable manner. Here, a web-based software system called GeneWeaver 
(www.geneweaver.org) (11) is described that facilitates convergent analyses 
across multiple genomic experiments, data sources, platforms and species (11). 
Using this system, we demonstrate the integration of empirically derived QTL 
mapping results with other relevant genomic data sets, with the aim of 
nominating highly likely QTG.  
The QTL mapping results described here are for cocaine-induced 
locomotor activation in the recently expanded BXD RI genetic reference 
population (164). Drug (here, cocaine) induced locomotor activation is an animal 
model focused on a very specific and important characteristic of human drug 
abuse, i.e., initial sensitivity to drugs. Furthermore, given the heritable and 
complex nature of cocaine-induced locomotor activation, it is readily amenable to 
the approach of QTL mapping and has been mapped previously in multiple 
studies (20, 82, 100). To date, 13 chromosomes and multiple chromosomal 
regions have been identified. However, a cocaine-induced activation QTG is yet 
to be discovered. Here, using these previously published results in conjunction 
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with relevant genomic data sets within the framework of GeneWeaver (12), a 
putative QTG is nominated. 
Once a QTG has been nominated, confirmation of the gene as the QTG 
necessitates in vivo assessment of the gene. Multiple approaches exist for the in 
vivo assessment of QTGs, including targeted gene knockouts, transgenic 
overexpression and rescue and viral mediated RNA interference. Of these, the 
targeted gene knockout approach is utilized here. The targeted gene knockout 
approach assesses the role of the QTG by nullifying its function in an otherwise 
normal animal. The detection of significant differences in the trait of interest in a 
comparison of null to control animals enables further validation and serves as 
evidence of the gene as the QTG.  
Methods 
QTL mapping in the BXD RI 
QTL mapping for cocaine-induced locomotor activation after the second 
intraperitoneal (ip) injection of 10 mg/kg of cocaine was performed in combined 
male and female, male only and female only BXD RI strains using GeneNetwork 
(http://www.GeneNetwork.org) and R/QTL (33, 219). R/QTL was utilized for 
additional QTL model fitting and to ensure reproducibility of QTLs mapped in 
GeneNetwork.org. One thousand permutations were performed to obtain 
genome-wide suggestive and significant thresholds. Ninety-five percent 
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confidence intervals (CI) were obtained by extracting 1.5-LOD support interval 
around the peak marker for statistically suggestive and/or significant QTLs.  
Integrative functional genomic analysis of the candidate genes 
Positional candidate genes residing within the 1.5 LOD drop support 
interval of the Chr 4 and Chr 15 QTLs were deposited to GeneWeaver 
(www.geneweaver.org). These gene lists, called gene sets  in GeneWeaver, 
were integrated with a core collection of gene sets associated with cocaine, 
methamphetamine and nicotine. This core collection consists of empirically 
derived gene sets associated with mammalian phenotype (MP) and gene 
ontology (GO) annotations, previously published QTLs, gene expression studies 
obtained from either the Neuroscience Information Framework 
(http://www.neuinfo.org) or previous publications, striatal and nucleus accumbens 
basal gene expression obtained from Allen Brain Atlas (http://www.brain-
map.org), polymorphic genes among the BXD RI strain panel and lastly, BXD 
gene expression correlates for striatal and nucleus accumbens to locomotor 
response after the second ip injection of 10 mg/kg of cocaine using GeneNetwork 
(http://www.GeneNetwork.org). The complete list of gene sets used in this 
analysis is provided in Appendix Table A1. 
for the integrative analysis 
of each of the two candidate gene sets with the above defined core collection of 
gene sets (12). The result obtained using Phenome Map is a hierarchical 
representation of gene-to-gene set interactions across the diverse collection of 
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gene sets, such that gene(s) shared across a greater number gene sets are 
placed at the top of this map. The Phenome Map tool also enables the 
generation of a gene-to-gene set association matrix that can be used to calculate 
gene membership counts. The gene membership counts can be used to rank 
each list of positional candidates to obtain a ranked list (or prioritized list) of 
positional candidates for functional validation. 
Assessment of Rab3b polymorphisms 
The Variant Brower interface in GeneNetwork (33, 36, 219) was queried 
for the presence of SNPs among the C57BL/6J (B6) and DBA/2J (D2) strains for 
Rab3b. Once locations for SNPs were retrieved, Integrative Genomics Viewer 
2.0 was used for the extraction of genomic regions for transcription factor binding 
(105) were imported in to IGV. 
For the prediction of transcription factor binding sites, 1Kb upstream of Rab3b 
was used. The B6 and D2 sequences were analyzed for putative TFBS using 
AliBaba 2.1 (80). Putative TFBS were then scanned for the presence of the two 
upstream polymorphisms. For the assessment of cryptic splice sites, nucleotides 
 19 bp upstream and downstream of the SNP location (for B6 and D2) were 
extracted and compared against consensus splice donor, branch and acceptor 
sites. Figure 4-1 depicts the consensus eukaryotic sequence logos, obtained 




Figure 4-1. Donor, branch and acceptor consensus sequences (227). 
Consensus sequences for the determination of cryptic splice sites. GT, A and AG 
are the most frequently seen dinucleotides at donor, branch and acceptor 
sequences, respectively. 
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Generation of mice with targeted deletions in Rab3a; Rab3b; Rab3c 
and/or Rab3d function has been previously described (184). Rab3a 
heterozygous and Rab3bcd triple null mice were obtained from The Jackson 
Laboratory (Strain Name: B6;129-Rab3btm1Sud Rab3atm1Sud Rab3dtm1Rja 
Rab3ctm1Sud/J ; Stock Number: 006375) and bred to produce obligatory Rab3bcd 
triple heterozygous (Rab3bcd+/-) and triple null (Rab3bcd-/-) offspring.  Ninety-six 
mice belonging to three genotype (C57BL/6J, Rab3bcd+/- and Rab3bcd-/-) and 
both sexes were tested. Age and sex matched mice were randomly assigned to 
the following groups: saline (SAL) and cocaine (COCA). Mice were between 56 
and 132 days of age at the start of behavioral testing.  All mice were maintained 
at The Jackson Laboratory in climate- and 12 h light cycle-controlled rooms and 
provided acidified water and 5K52 chow (LabDiet/PMI Nutrition, St. Louis, MO) 
ad libitum. The Jackson Laboratory Animal Care and Use Committee approved 
all protocols involving mice. 
Breeding and genotyping 
Mutant mice, B6;129-Rab3btm1SudRab3dtm1RjaRab3ctm1Sud/J carrying 
targeted mutations in Rab3b, Rab3c and Rab3d genes were acquired from the 
Jackson Laboratory Repository (JR#006375). Production of these mice has been 
described by Schluter and colleagues (184).  Briefly, all genes were targeted 
using a neomycin resistance gene to replace exons encoding either amino acids 
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1-76 of Rab3b or exons encoding amino acids 9-84 of Rab3c or Rab3d.  The 
constructs were independently electroporated into 129P2/OlaHsd ES cells. 
Chimeric mice were mated to C57BL/6J mice and the compound mutants 
created by intercrossing individual lines. The strain was backcrossed 2 or 3 times 
to C57BL/6J before being deposited in the repository. Homozygous triple null 
mice were received and maintained by sibling crosses. Heterozygous triple nulls 
were produced by crossing to C57BL/6J. 
In order to isolate the Rab3b null allele from the Rab3c and Rab3d 
knockout alleles (and produce B6.129P2-Rab3btm1sud mice), the triple mutants 
were additionally backcrossed to C57BL/6J for 3 or 4 times, selecting for the 
Rab3b heterozygotes and Rab3c and Rab3d wild-type loci at each generation.  
Experimental Rab3b-/-, Rab3b+/- and Rab3b+/+ mice were generated by 
intercrossing Rab3b+/- mice. Progeny were produced in the expected 1:2:1 ratio. 
All mice were genotyped for the presence of the wild-type or mutant Rab3b, 
Rab3c or Rab3d locus by PCR (184) on genomic DNA isolated from peripheral 
blood collected by retro-orbital plexus or submandibular bleeding.  
Behavioral analysis 
Assessment of acute and sensitized response to cocaine-induced 
locomotor activity 
Prior to testing, mice from all three genotypes (C57BL/6J, Rab3bcd+/- and 
Rab3bcd-/-) were randomly assigned either to a saline (SAL) or cocaine (COCA) 
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group. Mice were brought from their home room into the test room and allowed to 
habituate for one hour. Mice were administered either saline or cocaine (10 
mg/kg) by ip injection. Immediately post injection, mice were placed in an open 
field box and locomotor activity was recorded for a duration of 20 minutes using 
the EthoVision XT 8 video tracking and analysis system (Noldus Information 
Technology, Wageningen, The Netherlands). On Days 1 and 2 of testing all mice 
received saline. Day 1 measures locomotor activity in response to injection stress 
and novel environment, while Day 2 measures locomotor activity within a familiar 
environment and attenuated injection stress. On Days 3, 5, 7 and 9, mice 
received their assigned saline or cocaine injection ip.  
Assessment of habituation and its effect on cocaine induced 
locomotor activity. 
 Prior to testing mice from all three genotypes (C57BL/6J, Rab3bcd+/- and 
Rab3bcd-/-) were randomly assigned to one of three groups  Group A, B or C. 
Group A received saline on all three consecutive days of testing. Group B 
received saline on Days 1 and 2 and cocaine (10 mg/kg by ip) on Day 3. Group C 
received cocaine (10 mg/kg by ip) on Day 1 only. Group A serves as the baseline 
group, while Group B facilitates the assessment of cocaine induced locomotor 
activation following two days of habituation. Group C enables the assessment of 
cocaine induced locomotor activation in a novel environment, as mice belonging 
to this group have not been exposed to test apparatus. Immediately post 
injection, mice were placed in an open field box and locomotor activity was 
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recorded for a duration of 20 minutes using the EthoVision XT 8 video tracking 
and analysis system (Noldus Information Technology, Wageningen, The 
Netherlands).  
Tissue retrieval 
All mice across the three genotypes (C57BL/6J, Rab3bcd+/- and Rab3bcd-
/-) subjected to behavioral testing were sacrificed via decapitation 24  48 hrs 
following the last behavioral trial. In addition to these three genotypes, a naïve 
group of mice representing C57BL/6J (n = 8), DBA/2J (n = 8) and Rab3bcd-/- (n = 
8) were also sacrificed via decapitation in an attempt to obtain baseline levels of 
gene expression for Rab3b (C57BL/6J and DBA/2J) and Cartpt (C57BL/6J and 
Rab3bcd-/-). Striatal regions were extracted and total striatal RNA was isolated. 
Striatal RNA from naïve C57BL/6J (n = 8) was used in the analysis of Rab3b 
transcript abundance and Cartpt expression. Striatal RNA from naïve DBA/2J (n 
= 8) was used in the analysis of Rab3b transcript lengths. Striatal RNA from 
naïve Rab3bcd-/- was used in the analysis Cartpt expression  
Statistical analysis 
Statistical analyses were performed in JMP 9.0 (SAS Institute Inc., 
Raleigh, NC). For the assessment of intra-session habituation, for days 1 and 2 
data were binned into five-minute epochs and activity change scores were 
calculated using the following formula:  activity during the initial five minutes / 
[activity during the initial five minutes + activity during the final five minutes] 
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(119). Mean activity change scores across all three genotypes for each of the two 
days were calculated. These scores were compared with an activity change 
score of 0.5 (representing no habituation). Significantly different and lower mean 
activity change scores from 0.5 are representative of normal intra-session 
habituation. For acute response to cocaine, total distance travelled in 20 minutes 
(TD20) on Day 2 was subtracted from TD20 on Day 3 was analyzed using a one-
way analysis of variance (ANOVA), with genotype as the only factor. Similarly, for 
assessment of sensitized response to cocaine, TD20 on Day 3 was subtracted 
from TD20 on Day 9 and analyzed using a one-way ANOVA. Following each 
ANOVA, planned contrast statements were utilized to test for significant 
differences among the levels of genotype. To assess locomotor response 
following repeated exposure to cocaine, a repeated measures ANOVA was 
performed. For this analysis day was the within-subject variable and genotype as 
the between-subjects variable. 
qRT-PCR 
Briefly, tissue samples were stored in RNAlater (Life Technologies, 
Carlsbad, CA) per manufacturer's instructions and homogenized in TRIzol (Life 
Technologies, Carlsbad, CA). Total RNA was isolated by standard TRIzol® Plus 
digestion. The quality of the isolated RNA was assessed using an Agilent 2100 
Bioanalyzer instrument and RNA 6000 Nano LabChip assay.  500ng of total RNA 
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was then reverse transcribed with random decamers and M-MLV RT using the 
Message Sensor RT Kit (Life Technologies, Carlsbad, CA). 
Results 
QTL mapping  
Cocaine-induced locomotor activation (second ip injection of 10 mg/kg of 
cocaine) was previously mapped separately in BXD RI males and females. No 
QTL were detected in the males. In the females, on the other hand, suggestive 
QTL were detected on Chr 4 and Chr 15 respectively (p < 0.63, Figure 4-2). The 
two QTL additive model involving Chr 4 (rs13477919 @ 104.96 Mb) and Chr 15 
(rs13482528 @ 38.82 Mb) accounted for 34.40 % of the trait variance. Taken 
independently, the Chr 4 and Chr 15 QTLs accounted for 11.71 % and 15.65 % 
of the trait variance respectively. No significant interaction among these loci was 
detected. Furthermore, at each of these loci the DBA2/J (D2) allele is the 
increasor allele (Figure 4-3A,B) A genome-wide pair scan was also performed, 
resulting in the detection of a significant Chr 4 (rs13477881 @ 103.31) x Chr 5 
(rs3723202 @ 91.57) interaction (Figure 4-3C, p < 0.001). Inclusion of this 
interaction term increases the % variance accounted for by the model to 55.40%. 
1.5 LOD support intervals were used to define the 95% CIs. The Chr 4 (COCIA 
Chr4) CI spans 101.10 (rs13477873)  114.51 (gnf04.110.583) Mb, while the Chr 
15 (COCIA Chr15) CI spans 33.43 (rs8267966)  45.11 (rs13482547) Mb (Figure 





Figure 4-2. QTL Mapping of cocaine-induced locomotor activation in the 
expanded BXD RI panel. 
QTL mapping of locomotor response following the second injection of cocaine in 
females resulted in the detection of suggestive QTLs on Chr 4 and Chr 15. Green 
lines indicate that DBA/2J is the increaser allele, while red lines indicate that 





Figure 4-3. Main and interaction effect plots. 
A) Effect plot for the peak marker on Chr 4 (rs13477919 @ 104.96 Mb) indicates 
a significant effect of genotype (p < 0.0003). Furthermore at this locus the D2-
derived allele is the increasor allele. B) Effect plot for the peak marker on Chr 15 
(rs13482528 @ 38.82 Mb) indicates a significant effect of genotype (p < 0.0001). 
C) Interaction plot for the significant Chr 4 (rs13477881 @ 103.31 Mb) x Chr 5 
(rs3723202 @ 91. 67 Mb) (p < 0.0001). There is a significant difference in the 
phenotypic values when the genotypes at rs3723202 and rs13482528 are BB, 












































































































Figure 4-4. Chromosome 4 and Chromosome 15 QTL LOD support 
intervals. 
The black horizontal lines represent the 1.5 LOD support interval on Chr 4 (A) 
and Chr 15 (B). The LOD support interval on Chr 4 spans 101.10 (rs13477873)  
114.51 (gnf04.110.583) Mb, while on Chr 15 it spans 33.43 (rs8267966)  45.11 
(rs13482547) Mb. 108 and 61 positional protein coding candidate genes reside in 





searching for genes underlying the flanking marker coordinates in Mouse 
Genome Informatics (MGI; http://informatics.jax.org). Each gene list was 
uploaded to GeneWeaver.org (11) for integrative functional genomic analysis.  
Integrative functional genomic analysis reveals Rab3b as a putative QTG 
acute cocaine response 
A term search involving keywords pertaining to cocaine, 
methamphetamine and nicotine was performed in GeneWeaver (11) followed by 
a closer inspection of the search results, gave a total of 122 gene sets with an 
average of 72.41 genes per gene set spanning 21 publications. The Phenome 
Map analysis tool in GeneWeaver was used to construct an empirically derived 
hierarchical representation of the input gene sets for both the Chr 4 and Chr 15 
candidate gene list. A ranked list of genes was obtained using the gene-to-gene 
set connectivity metric. Rab3b was the most highly ranked gene (gene-to-gene 
set connectivity = 7) across Chr 4 (Figure 4-5) and Chr 15. The most highly 
connected gene on Chr 15 in this analysis has a gene-to-gene set connectivity of 
four. Additional analysis of Rab3b reveals that Rab3b is polymorphic among the 
BXD RI panel with 46 intronic polymorphisms, specifically within introns 1 and 2 
(Table 4-1).  Additionally, a search for polymorphisms less than 1Kb upstream 
from Rab3b revealed the presence of two upstream polymorphisms. These 
upstream polymorphisms were investigated further for the possibility of serving 
as transcription factor binding sites (Table 4-1). Polymorphism at or near 





Figure 4-5. Integrative functional analysis in GeneWeaver (11). 
A) Phenome map tool depicting a hierarchical representation of gene sets used 
in the integrative analysis. Nodes at the top are highly connected genes. Pink 
colored nodes represent nodes containing one or more QTL candidate genes. 
Rab3b is revealed as the most highly connected QTL candidate gene. B) 
GeneSet graph representing the underlying interconnections among the genes 
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Table 4-1 Consequence of upstream and intronic polymorphisms between 
C57BL/6J and DBA/2J. 
 
Table 4-1 continued. 
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Table 4-1 continued. 
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Furthermore, Rab3b is expressed in the dorsal and ventral striatum, down-
regulated in C57BL/6J and up-regulated in C3H/HeJ after exposure to nicotine 
(218), differentially expressed in D1 receptor mutants when compared to their 
wild-type controls after saline treatment (236) and is differentially expressed in 
the striatum in a recent RNA-Seq gene expression analysis across the C57BL/6J 
and DBA/2J BXD RI founder strains (21). Additionally, Rab3b is a candidate 
gene among three previously published QTLs, all of which were mapped in the 
BXD RI reference population, namely climbing in response methamphetamine 
(82), repeated movements following cocaine (100) and hypothalamic Cart 
abundance (20). In each of the three QTLs, the D2 derived alleles underlie the 
QTL, which is the case for our cocaine-induced locomotor activation QTL on Chr 
4 (COCIA Chr4).  
Remapping of previously published QTLs 
Three previously published QTLs overlap COCIA Chr 4 QTL, namely, 
CART transcript abundance (Crq2) (20), methamphetamine related climbing 
response (82) and cocaine related behavior (Cocrb5, repeated movements at 5 
mg/kg) (100). The advantages of utilizing previously published QTLs are: a) to 
achieve reduction in the QTL interval by overlapping the previously published 
QTLs on to the cocaine-induced activation QTL and b) to show that locomotor 
behaviors after exposure to drugs that affect the dopaminergic system, such as 
cocaine and methamphetamine, co-map to a common genomic region in multiple 
independent studies. In an attempt to obtain accurate peak marker locations and 
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confidence intervals based on the updated BXD genotypes and mouse genome 
builds, each of the three previously published QTLs were remapped. However, 
the results of this undertaking were rather surprising. None of the peak markers 
on Chr 4 that were originally reported were reproducible (Table 4-2). A closer 
inspection of the BXD genotypes used reveals that the peak loci initially reported 
are no longer represented in the most recent BXD genotypes, except for Crq2. 
The peak marker on Chr 4 for Crq2 is D4Mit249. When marker regression is 
performed using D4Mit249 alone, the marker remains significantly associated 
with Cart abundance (F (1,23) = 6.96, p < 0.0147). Legacy marker data are 
available for Adpf (currently, Plin2) and Mshm6 in MGI. Using these data, a point 
biserial correlation analysis was performed (as done in the original publications). 
Both markers remain significantly correlated with their corresponding trait data 
(Adpf; r = 0.67, p = 0.0008; Mshm6: r = 0.51, p = 0.0107). This suggests due to 
the inclusion of additional markers in current BXD genotypes, there exists newer 
markers that have better associations with the underlying behavioral data and 
hence mask the detection of the original peak loci resulting in a failure to 
reproduce the original QTLs. 
Assessment of Rab3b polymorphisms 
Forty-six intronic and two upstream polymorphisms exist between B6 and D2 
(Table 4-1). The upstream polymorphisms, if within potential promoter binding 
sites, transcription start sites or transcription factor binding sites, could result in 
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could result in the creation of cryptic splice sites due to the presence of new 
splice acceptor, branch and donor sites. To assess the effect of the upstream 
polymorphisms, 1 Kbp upstream of Rab3b (specific to B6 and D2) were extracted 
for the determination of its promoter region, transcription start site and potential 
transcription factor binding sites. Both strain sequences have the same predicted 
promoter region, transcription start sites and transcription factor binding sites. 
However, an upstream polymorphism (wt37-4-108551617, B6: A> D2: T) exists 
at a predicted transcription factor binding sites for nuclear factor 1 or Nf-1.  
Assessment of B6 and D2 sequences around the location of the 
polymorphisms revealed the presence of putative splice branch sites, a splice 
donor site and a splice acceptor site. The two potential splice branch sites are 
located at 108.553715 Mb (wt37-4-108553715, B6: G> D2: A) and 108.554864 
Mb (wt37-4-108554864, B6: G> D2: A), respectively. Both loci are within intron1-
2 and contain the sequence TTGATT (D2), which closely resembles the 
consensus splice branch site sequence (TCCT(A/G)A(C/T)). The splice donor 
site is located at 108.557288 (wt37-4-108557288, B6: C> D2: T) within intron1-2 
and contains the following sequence TTAGTGTAA (D2). The splice acceptor site 
is located at 108.568303 (wt37-4-108568303, B6: G> D2: A) within intron2-3 and 
consists of the following sequence CATTCAGG (D2). The donor and splice site 
sequence present in D2, closely resembles their corresponding consensus 
sequences (Figure 4-1). 
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Assessment of cocaine response in Rab3bcd triple null mice 
 
Preliminary in vivo assessment for the role of Rab3b in cocaine response 
was performed using targeted gene disruption. Rab3b knockout mice were not 
readily available but were available by proxy as a triple knockout in combination 
with Rab3c and Rab3d. Rab3c and Rab3d are also members of the Rab3 family, 
as are Rab3a and Rab3b. All Rab3 family members, except for Rab3d localize 
on synaptic vesicles. As a whole, Rab3's are involved in regulated exocytosis. 
Breeding is ongoing for the derivation and purification of Rab3b single knockout. 
 However, the Rab3bcd triple knockout enables the preliminary assessment of 
cocaine response involving a similar set of gene products. There exists the 
possibility that manifestation of abnormal cocaine response could be in part due 
to elimination of Rab3c and Rab3d, but it should be noted that the COCIA Chr 4 
QTL harbors neither of these genes.  
Habituation  
Assessment of inter- (Figure 4-6A) and intra-session (Figure 4-6B) 
habituation on Day 1 and Day 2 revealed that Rab3bcd-/- mice fail to habituate. 
To assess intra-session habituation, data were binned into five-minute intervals 
C57BL/6J and Rab3bcd+/- mice showed typical habituation curves, i.e. 
decreasing locomotor activity over time intervals. Rab3bcd-/- mice, however, 
displayed typical habituations patterns for intra-session habituation only on Day 2 
(Figure 4-6A). Statistically, intra-session habituation can be determined by 







Figure 4-6. Habituation deficits in the Rab3bcd-/-. 
A) Assessment of intra-session habituation reveals that Rab3bcd-/- mice show 
abnormal habituation curves. Unlike C57BL/6J and Rab3bcd+/-, Rab3bcd-/- mice 
show no decrease in distance travelled over the 20 min test period. Assessment 
of activity change scores revealed that C57BL/6J and Rab3bcd+/- had normal 
habituation patterns, i.e. significantly different from the activity change score of 
0.5 (no habituation) on Day 1 (C57BL/6J: t = -2.95, df = 31,p = 0.006; Rab3bcd+/-: 
t = -2.71, df = 31, p = 0.011) and Day 2 (C57BL/6J: t = -8.24, df = 31,p < 0.0001; 
Rab3bcd+/-: t = -4.10, df = 31, p = 0.003). Rab3bcd-/- mice showed significantly 
different from the activity change score of 0.5 only on Day 2 (Rab3bcd-/-: Day 1: t 
= -2.89, df =2 9, p = 0.775; Day 2: t = -2.31, df = 29, p = 0.027). B) Compared to 
C57BL/6J and Rab3bcd+/-, Rab3bcd-/- had a marginal increase in total distance 
travelled on Day 2 compared to Day 1. Additionally, C57BL/6J depicted 
significant decreases in locomotor activity on Day 2 compared to Day 1 (p < 
0.0001). While the Rab3bcd+/- exhibit decreased locomotor activity on Day 2 
compared to Day 1, this decrease was not significant (p = 0.1175). These two 




during the initial five minutes + activity during the final five minutes]) (119). 
Activity change scores equal to or nearing 0, 0.5 and 1 are representative of 
habituation, no habituation and increased activity compared to the initial time 
period, respectively. Mean activity change scores for C57BL/6J, Rab3bcd+/- and 
Rab3bcd-/- mice on Day 1 were 0.45 (SEM = 0.02), 0.46 (SEM = 0.01) and 0.50 
(SEM = 0.01), respectively. On Day 2 mean activity change scores for C57BL/6J, 
Rab3bcd+/- and Rab3bcd-/- mice were 0.41 (SEM = 0.01), 0.45 (SEM = 0.01) and 
0.48 (SEM = 0.01), respectively. Comparison of mean activity change scores to 
an activity change score of 0.5 (representing no habituation) facilitates 
determination of the extent of intra-session habituations among the three 
genotypes on days 1 and 2. On Day 1, mean activity change scores for 
C57BL/6J and Rab3bcd+/- were statistically different and lower compared to 0.5 
(C57BL/6J: t = -2.95, df = 31,p = 0.006; Rab3bcd+/-: t = -2.71, df = 31, p = 0.011). 
Inter-session habituation revealed that while C57BL/6J and Rab3bcd+/- mice 
show decreased locomotor activity on Day 2 compared to Day 1, Rab3bcd-/- mice 
show a marginal increase in locomotor activity (Figure 4-6B). Specifically, 
C57BL/6J had significant differences in locomotor activity on Day 1 (Mean = 
5946.41, SEM = 196.08) compared to Day2 (Mean = 4979.40, SEM = 175.67) (t 
= -4.63, df = 31, p < 0.0001). The decrease in locomotor activity for Rab3bcd+/- 
mice on Day 1 (Mean = 5329.72, SEM = 171.41) compared to Day 2 (Mean = 
4943.46, SEM = 203.39) was non-significant (t = -1.61, df = 31, p = 0.117). 
Similarly, the marginal increase in locomotor activity on Day 1 (Mean = 5709.17, 
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SEM = 201.50) compared to Day 2  (Mean = 5999.13, SEM = 321.62) for the 
Rab3bcd-/- was also non-significant (t = 1.1, df = 29, p = 0.280). Furthermore, 
over the duration of the behavioral testing protocol, among the SAL group of 
mice, Rab3bcd-/- showed consistently greater locomotor activity post saline on 
days 2, 3, 5, 7 and 9 compared to C57BL/6J and Rab3bcd+/- mice (Table 4-3, 
Figure 4-7).  
Acute response to cocaine 
Analysis of acute response to cocaine (Day 3COCA – Day 2SAL) revealed a 
significant effect of Treatment ! Genotype (F (2,2) = 6.04, p < 0.003) (Figure 4-
8). Specific tests for significant effects of genotype for the COCA and SAL groups 
were performed using planned contrasts statements. Planned comparisons 
revealed a significant effect of genotype for the COCA groups of mice (F (2,90) = 
10.75, p < 0.0001) and not the SAL group (F (2,90) = 0.08, p < 0.92). Within the 
COCA group, Rab3bcd -/- mice had the greatest change in locomotor response 
following cocaine compared to Rab3bcd +/- and C57BL/6J (Figure 4-8). 
Response to repeated exposure to cocaine 
A repeated measures analysis of variance approach was used to assess 
locomotor response following repeated exposure to cocaine (repeated factor 





Figure 4-7. Consistent increase locomotor activity in saline-treated 
Rab3bcd-/-. 
Rab3bcd-/- showed consistently greater locomotor activity following saline 
compared to C57BL/6J and Rab3bcd+/- mice on all days except Day 1. * indicate 




Figure 4-8. Rab3bcd-/- and acute cocaine response. 
Acute response to cocaine measured here, as the difference in total distance 
travelled on Day2 (post saline) from that on Day3 (post cocaine) for the Cocaine 
group indicates that Rab3bcd-/- mice have a significant increase in change in 
locomotor activity following cocaine compared to Rab3bcd+/- and C57BL/6J mice. 
No significant differences exist across the three genotypes among the mice 






Table 4-3. Assessment of baseline locomotor differences in Rab3bcd-/-. 
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Difference LCL UCL p 
1 
C57BL/6J Rab3bcd+/- 616.69 281.76 -54.42 1287.79 0.08 
C57BL/6J Rab3bcd-/- 333.07 281.76 -338.03 1004.18 0.47 
Rab3bcd-/- Rab3bcd+/- 283.62 281.76 -387.49 954.72 0.57 
        
2 
Rab3bcd-/- Rab3bcd+/- 1007.27 334.59 210.34 1804.19 0.01* 
Rab3bcd-/- C57BL/6J 971.33 334.59 174.4 1768.25 0.01* 
C57BL/6J Rab3bcd+/- 35.94 334.59 -760.99 832.87 0.99 
        
3 
Rab3bcd-/- C57BL/6J 1313.46 427.37 278.46 2348.47 0.01* 
Rab3bcd-/- Rab3bcd+/- 1179.46 413.79 177.32 2181.61 0.02* 
Rab3bcd+/- C57BL/6J 134 427.37 -901.01 1169.01 0.95 
        
5 
Rab3bcd-/- Rab3bcd+/- 1453.04 483.3 282.56 2623.52 0.01* 
Rab3bcd-/- C57BL/6J 1307.62 499.15 98.76 2516.49 0.03* 
C57BL/6J Rab3bcd+/- 145.41 499.15 -1063.45 1354.28 0.95 
        
7 
Rab3bcd-/- C57BL/6J 2073.86 485.82 897.28 3250.44 0.001* 
Rab3bcd-/- Rab3bcd+/- 1407.8 470.4 268.58 2547.02 0.01* 
Rab3bcd+/- C57BL/6J 666.06 485.82 -510.52 1842.64 0.36 
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Difference LCL UCL p 
9 
Rab3bcd-/- C57BL/6J 1778.71 474.66 629.17 2928.25 0.001* 
Rab3bcd-/- Rab3bcd+/- 1205.1 459.58 92.06 2318.14 0.03* 
Rab3bcd+/- C57BL/6J 573.61 474.66 -575.93 1723.15 0.45 
 




the Greenhouse-Geisser Epsilon (G-G) and the Huynh-Feldt Epsilon (H-F) were 
used for the assessment of the day ! genotype effect. No significant effect of day 
! genotype (F (6,132) = 0.72, G-G: p < 0.61, H-F: p < 0.62) was detected (Figure 
4-9).  
Sensitized response to cocaine 
In addition to assessing the effects of repeated exposure to cocaine in this 
panel on mice, we also assessed the development of cocaine sensitization. 
Analysis of cocaine sensitization calculated as Day 9COCA – Day 3COCA 
locomotion revealed no significant effect of Genotype (F (2,2) = 1.39; p < 0.25).  
Effect of habituation on cocaine induced locomotor activation 
Assessment of the effect of habituation on cocaine induced locomotor 
activation led to the manifestation of a significant habituation x genotype 
interaction (F (1,2) = 4.25, p < 0.03). On Day 1, C57BL/6J (Mean = 16815.36, 
SEM = 1535.22) and Rab3bcd+/- (Mean = 16018.17, SEM = 1535.22) mice 
showed increased cocaine induced locomotor activation compared to Rab3bcd-/- 
(Mean = 11481.20, SEM = 1880.26) mice. Furthermore, following two days of 
habituation C57BL/6J (Mean = 8594.24, SEM = 1535.22) and Rab3bcd+/- (Mean 
= 10876.61, SEM = 1535.22) exhibited reduced amounts of cocaine induced 
locomotor activation compared to Day 1. Unlike the C57BL/6J and Rab3bcd+/-, 




Figure 4-9. Rab3bcd-/- and lack of sensitized cocaine response. 
On Days 1 and 2 all mice have approximately the same amount of distance 
travelled following saline injections.  Over the course of the experiment Rab3bcd-
/- mice have higher baseline locomotor activity compared to Rab3bcd+/- and 
C57BL/6J. Administration of cocaine (Days 3,5 7 and 9) results in an increase in 
locomotor activity for all three genotypes compared to the saline treated group 
with Rab3bcd-/- exhibiting the highest amount of locomotor activity across the 
three genotypes. Repeated measures ANOVA resulted in no significant increase 






locomotor activation on Day 3 (Mean = 12888.41, SEM = 1681.75) as compared 
to Day 1 (Mean = 11481.20, SEM = 1880.26). This result suggests that lack of 
habituation exhibited by the Rab3bcd-/- may affect the magnitude of cocaine 
induced locomotor activation observed. 
Differences in Rab3b transcript lengths between C57BL/6J and DBA/2J 
There are four transcripts of Rab3b according to the Vertebrate Genome 
Annotation database (VEGA) genome browser (7, 226). Of these four, two are 
CCDS or consensus coding sequences of different lengths, henceforth referred 
to as Rab3b-L (OTTMUST00000018722) and Rab3b-S 
(OTTMUST00000018724) transcripts. Rab3b-
compared to Rab3b-S. As a possible means of differential regulation of Rab3b 
between the BXD progenitors, namely B6 and D2, we sought to quantify 
transcript abundance using two TaqMan probes, namely, Mm01258423 and 
Mm00772238. Mm01258423 spans Exons 1-2 and hence would uniquely target 
Rab3b-L. Mm00772238 span Exons 3 4 and targets both Rab3b-L and Rab3b-
t values were analyzed for differential expression across the two strains. 
qRT-PCR results suggest that there is no differential expression between the two 





Table 4-4. !Ct values for probes targeting Rab3b-S and Rab3b-L transcripts. 
 
Transcript ID TaqMan Probe ID 
Exons 
spanned Identifier !Ct – Mean ± SE 
    C57BL/6J DBA/2J 
OTTMUST00000018724 Mm00772238 Exons 3–4 Rab3b-S 6.29 ± 0.08 6.2  ± 0.04 





CART transcript abundance in Rab3bcd -/- and C57BL/6J  
A previously published QTL mapping study involving CART transcript 
abundance (20) overlapped our COCIA Chr4 QTL. CART or cocaine- and 
amphetamine-regulated transcript peptide is involved in reward and 
feedingrelated behaviors. Studies in rats have shown that CART mRNA 
expression is upregulated after acute cocaine self-administration in brain regions 
of the mesocorticolimbic dopamine system (59). To assess the effects of 
Rab3bcd KO on cartpt expression, we analyzed CART expression using !Ct 
values to detect genotype (Rab3bcd -/- and C57BL/6J) ! treatment (naïve, SAL 
and COCA) effects (Table 4-5). The genotype x treatment effect was suggestive 
(F (1,2) = 2.58; p < 0.08). No significant differences were observed across 
genotypes for the naïve group, suggesting that baseline levels of Cartpt 
expression are not altered in Rab3bcd mutants. Planned contrasts were used to 
detect differences in CART expression following saline or cocaine treatment. 
Following saline and cocaine treatment Cartpt is differentially expressed across 
the two genotypes (SAL: F (1,42) = 10.03, p < 0.003; COCA: F (1,42) = 11.10, p 
< 0.002). Within genotype contrasts failed to detect any significant differences 
across the two treatments (Rab3bcd-/-: F (1,42) = 1.76, p < 0.19; C57BL/6J: F 
(1,42) = 1.84, p < 0.18). These results suggest that it is unlikely that disruption of 
Rab3bcd alone induces dysregulation of Cartpt. However, in combination with 
external factors, in this case repeated handling and injection stress, an increase 
in Cartpt expression was detected (Table 4-6). There was a significant genotype 
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Table 4-5. Cartpt !Ct values for C57BL/6J and Rab3bcd-/- among naïve, 
saline and cocaine treated mice. 
 
!! !Ct – Mean ± SE 
! Genotype 
Treatment C57BL/6J Rab3bcd-/- 
Naïve 10.24 ± 0.19 10.12 ± 0.23 
Saline 10.55 ± 0.11 9.75 ± 0.15 
Cocaine 10.22 ± 0.16 9.42 ± 0.18 
Gapdh was used in the calculations of !Ct. 
 
Table 4-6. Cartpt !Ct values for C57BL/6J and Rab3bcd-/- among naïve and 
challenged (saline and cocaine treated) mice. 
 
!! !Ct – Mean ± SE 
! Genotype 
Challenge C57BL/6J Rab3bcd-/- 
Naïve 10.24 ± 0.19 10.12 ± 0.23 
Challenge (saline or cocaine) 10.36 ± 0.11 9.58 ± 0.11 







! challenge (naïve or injection) effect when the cocaine and saline injected mice 
were collapsed and grouped as “challenge” (F (1,1) = 4.69; p < 0.03). Planned 
contrasts revealed a significant difference in Cartpt expression between 
Rab3bcd-/- naïve and injected mice (F (1,44) = 6.18; p < 0.02). No significant 
difference in Cartpt expression was detected between C57BL/6J, naïve and 
challenge mice (F (1,44) = 0.33; p < 0.57).  
Discussion 
The highly heritable component of alcoholism and drug addiction has led 
to numerous studies attempting to understand and characterize the genetic basis 
of addiction. One method that has been widely used for the unbiased detection of 
genomic regions harboring polymorphic candidate genes for complex traits is 
QTL mapping. Widespread utilization of this approach has resulted in the 
detection of large numbers of QTL harboring numerous candidate genes with 
only a handful of candidate genes within these QTL being successfully 
nominated and validated as the QTG. Most, if not all QTG have been identified 
using a combination of approaches such as fine mapping, sequence and 
expression level comparison of genes between progenitor strains or between 
congenics and background strains (138). While genetic methods have 
successfully identified QTGs, they have been extremely time- and resource- 
intensive, often-taking years and large numbers of mice (especially recombinant 
progeny required for fine-mapping a QTL interval). Complementary bioinformatic 
tools have been proposed as a means of accelerating QTG identification but to 
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date very few genes have been nominated as QTG (57, 84, 151). A strategy with 
tremendous potential in facilitating QTG discovery that has emerged over the last 
few years is integrative functional genomics. This strategy, as the name 
suggests, involves integration of candidate genes with empirically derived 
genome-scale information available via published studies that span multiple 
platforms, species, and curated data repositories, such as Mammalian 
Phenotype Ontology (MP,(194)), Gene Ontology (GO, (3)) and Kyoto 
Encyclopedia of Genes and Genomes (KEGG, (102)). This strategy has been 
successfully applied towards the analysis of bipolar disorder (117, 151). Existing 
integrative approaches suffer from a lack of cross-species integration, scalability 
and computationally efficient algorithms, in order to achieve true genome-wide 
integrative analysis. Cross-species integration is vital to facilitate translation of 
research findings from induced animal models to humans. To facilitate a 
theoretically comprehensive integrative analysis, i.e. no limit on the number of 
gene sets in the analysis, it is important that integrative approaches be scalable. 
By being computationally efficient, reasonable analysis run times can be 
achieved, making genome scale integrative analysis feasible.  
Presented here is the integrative functional genomic analysis of the 
candidate genes for a previously mapped cocaine-induced activation QTL in BXD 
RI strain panel (164). By incorporating multiple independent lines of evidence, it 
is possible to efficiently and seamlessly query a QTL interval, in an unbiased 
manner, and nominate QTGs. In the current analysis, empirical information was 
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derived from 21 published studies, totaling 122 genomic data sets. Using these 
genomic data sets Rab3b was identified as the most highly ranked (maximum 
gene to gene set connectivity) positional candidate for the COCIA Chr4 QTL.  
RAB proteins are proteins belonging to the family of Ras-like GTPases. 
These proteins are primarily involved in trafficking of secretory and endocytic 
vesicles of eukaryotic cells (133, 154). Sixty known RAB proteins exist, of these 
RAB  (85, 
197, 203). The RAB3 protein family consists of four homologous isoforms, 
namely, RAB3A, 3B, 3C and 3D RAB3A, 3B and 3D co-
localize on presynaptic vesicles, while RAB3D localizes on secretory vesicles on 
exocrine glands (72, 152, 183). RAB in regulated exocytosis and 
are involved in docking, priming and fusion stages of the synaptic vesicle cycle. 
Specifically, in vitro studies have revealed that RAB3 proteins inhibit Ca2+-
triggered exocytosis in PC12 cells (183). Additional lines of evidence support the 
involvement of RAB3 in inhibition of neurotransmitter release. Overexpression of 
GTPase-deficient mutants of RAB3 inhibits release of neurotransmitters and 
hormones (92, 93, 97, 171). Overexpression of the catalytic domain of RAB3 
GEP, which promotes the exchange of GDP for GTP on RAB3, reduces 
exocytosis (157). Decreasing the expression of Rab3a via antisense 
oligonucleotides microinjection, resulted in an increase in response to repetitive 
stimulations (97). In vitro and in vivo studies involving overexpression of Rab3b 
in dopamine neurons of the rat SN increases dopamine content, uptake, number 
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and size of synaptic vesicles, and levels of presynaptic proteins consistent with 
the results obtained in studies involving RAB3B (40). Within the synapse a 
number of putative effector proteins of RAB3 exist. These include RIMs (RIM1  
and RIM2 ), Rabphillin, NOC2, SNAP-25, synapsin, synaptogamin and CaM. 
Among these, it has been shown that disruption of RAB3A-CaM interaction (and 
not the other effector proteins) result in the lack of inhibition in exocytosis by 
RAB3 (46). Furthermore, overexpression of Rab3b also leads to an increase in 
CaM (190). Similar to disrupting the RAB3A-CaM interaction, one can 
hypothesize that disruption of the RAB3B-CaM interaction could also lead to 
RAB3 inhibition of exocytosis, primarily due to the redundant functionality and 
high degree of homology among the Rab3 proteins. 
While Rab3b involvement in inhibiting neurotransmitter 
release makes it a highly attractive candidate gene for drug addiction, is it a 
QTG? Using the characteristics of a QTG suggested by the Complex Trait 
Consortium (CTC) (5) and Glazier and colleagues (78), we show that Rab3b 
satisfies multiple criteria that makes it a highly likely and valid QTG. These are: 
a) Rab3b is polymorphic between the B6 and D2, the progenitor strains for the 
BXD RI genetic reference population. Two upstream and 46 intronic 
polymorphisms located within the first and second introns of Rab3b exist(Table 
4-2). Detailed analysis these polymorphisms using the recent Sanger 
resequencing project (105) revealed important insights regarding the nature of 
these polymorphisms. Of the two upstream polymorphisms, one (wt37-4-
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108551617, B6: A>D2: T) underlies the potential transcription factor binding site 
of nuclear factor 1(NF-1). This could potentially result in differential gene 
regulation of Rab3b across the B6 and D2 strains. Among the intronic 
polymorphisms, the D2 sequences of four SNPs closely resemble the consensus 
sequences for splice acceptor (wt37-4-108568303, B6: G>D2: A), branch (wt37-
4-108553715, B6: G> D2: A; wt37-4-108554864, B6: G> D2: A) and donor (wt37-
4-108557288, B6: C> D2: T) sites (Table 4-2). These polymorphisms could 
potentially create cryptic splice sites due to the presence of novel splice 
acceptor, branch and donor sites again resulting in differential regulation of 
Rab3b across B6 and D2 strains, b) Rab3b is expressed in brain regions relevant 
to cocaine related responses. It is expressed in the striatum, nucleus accumbens 
and the ventral tegmental area (www.brain-map.org). Each of these brain regions 
contain dopaminergic neurons and plays a central role in cocaine-mediated 
behaviors, c) Rab3b is differentially expressed following chronic nicotinic 
exposure across five brain regions in two inbred strains of mice, namely, 
C57BL/6J and C3H/HeJ (218). Specifically, Rab3b was down regulated in the 
nucleus accumbens of C57BL/6J mice, while being upregulated in the ventral 
tegmental area of C3H/HeJ mice. Furthermore, a recent RNA-Seq study has 
shown that Rab3b (p < 0.02, q-value < 0.07) is differentially expressed in the 
striatum of C57BL/6J and DBA/2J strains of mice (21). The differential 
expression of Rab3b across the two strains could be attributable to the presence 
of functional SNPS, i.e. cryptic splice sites and can be experimentally validated, 
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and d) The COCIA Chr4 QTL harboring Rab3b, has also been detected in three 
previous mapping studies for cart transcript abundance (20), methamphetamine 
related climbing response (82) and cocaine related behavior (repeated 
movements at 5 mg/kg) (100). It should be noted that we were not able to 
reproduce the results from the above-mentioned three original publications using 
new BXD genotypes and interval mapping. The non-reproducibility is in the 
location of QTLs upon remapping the original publications. Even though there is 
disparity in the location of the remapped QTLs compared to previously published 
QTLs, it must be noted that this disparity does not affect the results of the IFG 
analysis. Rab3b is still the most highly connected gene regardless of the 
inclusion of the previously published QTLs.  
To validate Rab3b as a QTG, an in vivo gene targeting approach was 
used. Rab3b KO mice are only available as a triple KO, which also involves 
Rab3c and Rab3d. Among the Rab3bcd-/- mice, two of the three RAB3 proteins 
that co-localize on presynaptic vesicles, namely Rab3b and Rab3c, are absent. 
Rab3d does not localize within synaptic vesicles (72, 152, 183) and may not be 
involved in regulated exocytosis. This could result in possible alterations in the 
inhibition of exocytosis by Rab3s. Given this, we would expect the Rab3bcd-/- 
mice to have increased neurotransmitter release (here dopamine), which 
behaviorally would result in increased locomotor activity following saline and 
cocaine treatment. As shown in Figure 4-7, this was in fact observed; Rab3bcd -/- 
mice consistently had increased locomotor activity post saline (suggesting 
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habituation deficits) compared to their Rab3bcd-/- and C57BL/6J mice throughout 
the length of the study. Furthermore, the cocaine response observed is an acute 
response (Figure 4-8) rather than a sensitized response (Figure 4-9). 
Interestingly, we also detected significant differences in Cartpt expression across 
naïve and treated Rab3bcd-/- mice. This suggests a role of Rab3bcd in Cartpt 
variation following external stressors, in this case repeated injection and handling 
stress. This is of additional value as one of the previously published QTLs 
overlapping the COCIA Chr4 QTL was for Cartpt expression in the BXD RI strain 
panel and mapped to a region on Chr 4 that contains Rab3b. The similar levels of 
Cartpt after saline and cocaine exposure might be attributed to the harvesting of 
brain regions after 24  48 hr from the last cocaine injection. 
Future work will involve backcrossing and purification of Rab3b-/- mice to 
N5 and higher, at which stage they can be considered as incipient congenic 
strains followed by assessment of acute cocaine response in the Rab3b single 
nulls. While functional validation of the Rab3b-/- mice will serve as proof of 
Rab3b
it is the QTG. Conclusive proof that Rab3b is the QTG can be obtained via 
additional fine-mapping of the QTL using RISTs (50). As this approach starts with 
recombinants among the RI strain panel within the QTL interval, it can readily be 
applied to the COCIA Chr4 QTL that was mapped in the BXD RI strain panel. 
The COCIA Chr4 QTL interval contains twelve recombinants, namely, BXD 13, 
15, 16, 28, 32, 43, 55, 67, 86, 87 90 and 100. Of these twelve, BXD 55 and BXD 
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86 are double recombinants. BXD 33 could also possibly be a double 
recombinant. BXD 15, 16, 28, 67 and 87 strains are best suited for the derivation 
of RISTs as they contain almost equal progenitor strain contribution in the QTL 
interval. There are two RIST populations, namely, RIST-F2 and RIST-BC, 
available for fine-mapping a QTL. Since the original QTL was detected in the 
BXD RI mapping population, which only allows for assessment of additive 
effects, the RIST-F2 approach will be most suited for fine mapping. Another 
approach that can be used to verify Rab3b as a QTG is to perform a QTL  
knockout interaction test or quantitative complementation test (52, 196). In order 
to do so, four strains are required. Two co-isogenic strains, one containing the 
this approach. The other tw
strain with the high and low strains, to obtain high/null and low/null F1 hybrids. 
Similarly, the wild-type (137) is crossed with the high and low strains to obtaining 
high/wt and low/wt F1 hybrids. A significant Line x Cross interaction in an 
ANOVA analysis is interpreted as evidence that the knockout is in fact the QTL. 
Rgs2 was validated as the gene underlying the QTL using this approach (230). 
However, the possibility that the significant interaction is due to the gene of 
interest interacting with loci on other chromosomes cannot be ruled out. An 
approach such as reciprocal hemizygosity, first applied for the dissection of 
quantitative traits in yeast (126), can help resolve such issues.  
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While the eventual proof of a candidate gene as the QTG lies in genetic 
approaches, in silico approaches can help point future studies in the right 
direction through the identification and nomination of putative QTG. As shown 
here, using an integrative functional genomics approach within the framework of 
GeneWeaver (www.geneweaver.org), Rab3b was identified as a putative QTG 
for acute cocaine response. GeneWeaver facilitates the detection of putative 
QTGs by its extensive and well-curated data repository of functional genomic 
studies that span multiple species and experimental platforms. In addition to this 
database and 
efficient graph theoretical algorithmic enable integrative analysis to be performed 
at a truly genomic scale. These features make GeneWeaver an extremely useful 
and applicable resource for the acceleration of QTG identification and nomination 




CHAPTER V: CONCLUSION 1 
 2 
The results presented here address the key issue for efficient nomination of 3 
Quantitative Trait Genes (QTG). Nomination and validation of a QTG is the end 4 
goal of all Quantitative Trait Locus (QTL) mapping studies. Despite the 5 
widespread utilization of QTL mapping, very few QTG have been nominated and 6 
validated. This is partly attributable to the power and resolution with which a QTL 7 
is mapped that depends heavily upon the genetic architecture of the mapping 8 
population or experimental crosses utilized. Frequently, the resolution 9 
(confidence interval; CI) of a mapped QTL is large and harbors numerous 10 
positional candidate genes, which makes the task of QTG nomination tedious. 11 
Improvements in statistical methodologies and experimental crosses have greatly 12 
improved the prospect of QTG nomination.  13 
To address the issue of efficient QTG nomination, the methodology and 14 
results assess the current and future state for QTL to QTG discovery by: 15 
• Assessing the power and resolution of QTL mapping in two recently 16 
developed experimental crosses, the BXD RI (Chapter II) and the 17 
collaborative cross (CC, Chapter III) 18 
• Presenting integrative functional genomics as an alternative in silico 19 
approach for the successful nomination of QTGs (Chapter IV).  20 
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QTL mapping in the expanded BXD Recombinant Inbred and the emerging 1 
collaborative cross mouse strains 2 
The BXD recombinant inbred (RI) strain panel has been a widely used 3 
mapping population for the study of complex traits. Prior to their recent 4 
expansion, the original panel of BXD RI strains (n = 26) was able to reliably 5 
detect QTLs accounting for 32% of trait variance (power = 0.90, alpha = 0.05) 6 
(18). QTL accounting for such large trait variance are representative of QTL 7 
underlying Mendelian rather than complex traits. Hence, genes underlying such 8 
QTL would be Mendelian rather than quantitative trait genes. Following the 9 
expansion, the number of RI strains in the BXD panel increased to approximately 10 
90 strains, facilitating the detection of QTL accounting for as little as 11% of trait 11 
variance (power = 0.90, alpha = 0.05). Additionally, the increased number of 12 
strains makes feasible the detection of epistatic interactions. In Chapter II, the 13 
recently expanded BXD RI strains were utilized for genetic analysis of a multitude 14 
of complex traits. In total, 257 behavioral traits were assayed across an average 15 
of 60 BXD RI strains. The majority of the traits were amenable to QTL mapping 16 
(broad sense heritability or h2 > 0.30) with better mapping resolution 17 
performance. Furthermore, QTLs accounting for approximately 16% of trait 18 
variance can be detected with 90% power (alpha = 0.05) using 60 BXD RI 19 
strains. Mapping resolution, determined using the 95% CI, revealed that the 20 
mean 95% CI of significant QTL (LOD > 3.2 (73)) was 12.5 cM, a considerable 21 
improvement from 20-30 cM that was achieved using the initial BXD RI strain 22 
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panel. Part of this improvement is attributable to dense marker maps, but it is 1 
largely due to the increased numbers of recombination events in the expanded 2 
BXD RI strains (162). Despite these improvements, the BXD RI strain panel 3 
suffers from the unavoidable constraint of limited genetic variation. On average, 4 
two progenitor RILs capture approximately 15% of available genetic variation 5 
(genetic variation captured in the BXD RILs is about 16%), primarily due to their 6 
shared ancestry and large haplotype blocks (162, 232, 233). The limited 7 
8 
Blind spots are regions of limited or no variation within RILs, which mask the 9 
presence and impede the detection of true QTLs (175). These limitations 10 
necessitate the generation of advanced experimental crosses, such as the CC. 11 
The CC is derived from eight inbred strains rather than two. The eight inbred 12 
strains chosen for the derivation of the CC are C57BL/6J, 129S1/SvImJ, 13 
NOD/LtJ, A/J, NZO/HiLtJ, CAST/EiJ, WSB/EiJ and PWK/PhJ (34, 42, 211). 14 
Three of the eight founder strains, namely, CAST/EiJ, PWK/PhJ and WSB/EiJ 15 
are wild-derived strains representing, M. m. castaneus, M. m. musculus and M. 16 
m. domesticus mouse sub-species, respectively. The eight combined inbred 17 
strains capture 89% of the available genetic variation (175). The increased 18 
genetic variation results in smaller regions of identity by descent (IBD) that 19 
consequently reduces the presence of blind spots. In addition to increased 20 
genetic variation, the CC is expected to have higher numbers of recombination 21 
events and larger numbers of independent genetically diverse RI strains, each a 22 
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fine-grained mosaic of the eight founder strains. The increased amount of genetic 1 
variation and higher number of recombinations are expected to greatly improve 2 
QTL mapping resolution in the CC, once completed. In Chapter III, an 3 
assessment of QTL mapping in the early breeding generations of the CC was 4 
performed. QTL mapping in this population achieved an average confidence 5 
interval (1.5-LOD support interval around the significant QTL peaks) of 3.98 Mb 6 
(approximately 2 cM) with an average of 50 positional candidate genes in these 7 
intervals (8, 165). This is a considerable reduction in QTL mapping resolution 8 
compared to the BXD RI strain panel. However, QTL mapping in the CC still 9 
does not achieve single gene resolution, necessitating additional fine mapping to 10 
further reduce the QTL interval. 11 
In silico reduction of QTL intervals 12 
Thus far almost all the QTGs nominated and validated have made use 13 
of genetic approaches. While successful, these approaches are considerably 14 
resource and time intensive, and do not necessarily expedite the process of QTG 15 
nomination and validation. To expedite QTG discovery, complementary 16 
bioinformatic tools have been developed. Unfortunately, current bioinformatic 17 
tools require considerable end-user involvement due to the disparate nature of 18 
empirically derived genomic data sets. This severely limits the ability with which 19 
they can be used to perform a truly cross-species and cross-platform oriented 20 
integrative genomic analysis. An approach that has emerged over the last few 21 
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years and has tremendous potential in addressing and resolving these issues is 1 
integrative functional genomics.  2 
The appeal of integrative functional genomics lies in its ability to 3 
facilitate convergent analyses across multiple genomic experiments, platforms 4 
and species (11). This approach can help expedite QTG discovery, as candidate 5 
genes within a QTL interval can be integrated with other relevant empirically 6 
derived genomic data sets across multiple species to nominate highly relevant 7 
QTG. In Chapter IV, the approach of integrative functional genomics is 8 
implemented using GeneWeaver (www.geneweaver.org) that facilitates 9 
computationally efficient integrative functional genomic analyses by providing 10 
comprehensive data sources and analytical toolsets (11). Using GeneWeaver, 11 
Rab3b is nominated as a putative QTG for a cocaine-induced locomotor 12 
activation QTL on Chr 4 mapped in the expanded BXD RI strain panel (164). 13 
Rab3b meets multiple criteria that justify its classification as a QTG, including 14 
relevant polymorphism (here, intronic cryptic splice site polymorphisms), 15 
differential expression in the striatum across C57BL/6J and DBA/2J inbred 16 
strains (21) and basal expression in mesocorticolimbic regions of the brain. 17 
Additionally, functional evaluation of the Rab3 complex in cocaine response was 18 
performed using mixed background Rab3bcd triple knockout (KO) mice (B6;129 19 
Rab3bcd-/-). This analysis revealed the role of Rab3b in acute cocaine response. 20 
Specifically, Rab3bcd-/- mice have increased cocaine-induced activation 21 
compared to Rab3bcd+/- and C57BL/6J mice in a test for acute cocaine response. 22 
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Conclusive evidence of Rab3b as the QTG will be obtained by: a) derivation and 1 
functional evaluation of the Rab3b single KO mice, b) additional fine-mapping of 2 
the cocaine-induced locomotor activation QTL on Chr 4 using recombinant inbred 3 
segregation tests (RISTs) and c) experimental validation of the potential splice 4 
branch site polymorphisms.  5 
The nomination of Rab3b as the putative QTG for cocaine-induced 6 
locomotor activation speaks to the utility and efficiency of integrative functional 7 
genomics and GeneWeaver. The analysis that led to its identification consisted of 8 
122 empirically derived genomic data sets spanning 21 publications. The efficient 9 
algorithm and database features within GeneWeaver resulted in rapid generation 10 
of a prioritized or ranked list of positional candidates within the cocaine-induced 11 
locomotor activation QTL, with Rab3b ranked first. Furthermore, no single study 12 
or line of evidence pointed towards Rab3b as the likely QTG. It was the 13 
convergence of suggestive results from these multiple independent studies that 14 
led to the nomination of Rab3b. This is an important point to note, since often 15 
times (and naturally) published results only contain significant findings with 16 
suggestive findings being either discarded or overlooked. In a field such as QTL 17 
mapping wherein suggestive evidence is acceptable, it is important to utilize all 18 
available information (significant or suggestive) for finding QTG underlying 19 
suggestive QTL. However, the results of such integrative analysis should be 20 
interpreted with extreme caution to ensure the validity of such findings. This 21 
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responsibility lies entirely in the hands of the researcher and must be undertaken 1 
prior to embarking upon any kind of biological validation of in silico findings.  2 
The future of QTG nomination and validation 3 
As advanced mouse genetic resources continue to become available, 4 
finding genes that underlie complex traits will undoubtedly occur at a faster pace 5 
with increased success. For example, the generation of the CC RI panel is 6 
nearing completion. As of 2011, approximately 100 CC strains were to be derived 7 
(211). The CC, as preliminary studies have revealed, will certainly improve QTL 8 
mapping resolution. Furthermore, mapping populations derived from the CC, 9 
such as the Diversity Outbred (DO), will also serve as a high-resolution mapping 10 
resource. In fact, QTL mapping studies in the DO, like the CC, have shown 11 
considerable improvements in QTL mapping resolution (125). Improved QTL 12 
mapping resolution results in fewer positional candidate genes, making the task 13 
of QTG nomination feasible. Applying the approach of integrative functional 14 
genomics to these positional candidate genes will aid in the rapid and efficient 15 
nomination highly relevant QTG. These putative QTG can then be readily 16 
validated using targeted transgenic mouse technologies. This step will be greatly 17 
expedited, in larger part due to the efforts of the Knockout Mouse Project (124) 18 
and the International Mouse Knockout Consortium (45), that are in the process of 19 
generating knockouts for all protein coding genes. These resources, in concert 20 
with high-throughput sequencing technologies such as RNA-Seq, will further aid 21 
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in the nomination of highly relevant QTG, facilitating an improved understanding 1 
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Table A1. List of gene sets used in the integrative functional genomic 3 
analysis using GeneWeaver (11). 4 
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Table A1 continued. 
Gene set 






Genetic influences on 
impulsivity, risk taking, 
stress responsivity and 




Distinctive profiles of gene 
expression in the human 
nucleus accumbens 
associated with cocaine 




both cocaine and 
heroin abusers 
GS1231 
Distinctive profiles of gene 
expression in the human 
nucleus accumbens 
associated with cocaine 
and heroin abuse. 
16710320 
Upregulated in both 
cocaine and heroin 
abusers 
GS1232 
Distinctive profiles of gene 
expression in the human 
nucleus accumbens 
associated with cocaine 
and heroin abuse. 
16710320 
Upregulated in 




Gene Expression in 
Human Hippocampus 
from Cocaine Abusers 







mechanisms for bipolar 
(manic-depressive) and 







Table A1 continued. 
Gene set 







dependent changes in 
gene expression in the 




Strain- and region-specific 
gene expression profiles 
in mouse brain in 





modulated by nicotine 
in five combined brain 
regions (Amyg, HP, 
NA, PFC and VTA) for 
C3H/HeJ mice 
GS14890 
Strain- and region-specific 
gene expression profiles 
in mouse brain in 




in five combined brain 
regions, Amyg, HP, 
NA, PFC and VTA, in 
C57BL/6J mice 
GS14891 
Strain- and region-specific 
gene expression profiles 
in mouse brain in 
response to chronic 
nicotine treatment. 
17504244 
Upregulated genes in 
five combined brain 
regions, Amyg, HP, 
NA, PFC and VTA, in 
C57BL/6J mice 
GS14892 
Strain- and region-specific 
gene expression profiles 
in mouse brain in 




in five brain regions, 
NA, PFC, and VTA, in 
C3H/HeJ mice 
GS14893 
Strain- and region-specific 
gene expression profiles 
in mouse brain in 
response to chronic 
nicotine treatment. 
17504244 
Upregulated genes in 
three brain regions, 
NA, PFC, and VTA, in 
C3H/HeJ mice 
GS14905 
Molecular genetics of 
nicotine dependence and 
abstinence: whole 
genome association using 
520,000 SNPs. 
17407593 Genes implicated in nicotine dependence 
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Table A1 continued. 
Gene set 






Molecular genetics of 
nicotine dependence and 
abstinence: whole 
genome association using 
520,000 SNPs. 
17407593 Genes implicated in smoking cessation  
GS14907 
Genome-wide association 
for nicotine dependence 
and smoking cessation 










for nicotine dependence 
and smoking cessation 









Gene profiling the 
response to repeated 
cocaine self-administration 
in dorsal striatum: a focus 




transcriptional response to 




Nicotine modulates the 
expression of a diverse 
set of genes in the 









Nicotine modulates the 
expression of a diverse 
set of genes in the 









Novel genes identified in a 
high-density genome wide 





Table A1 continued. 
Gene set 







receptor genes implicated 
in a nicotine dependence 
association study targeting 
348 candidate genes with 
3713 SNPs. 
17135278 
 Genes with SNPs 
associated with 
nicotine dependence  
GS26305 
Cholinergic nicotinic 
receptor genes implicated 
in a nicotine dependence 
association study targeting 






GWAS and SNP 
association methods 
GS26324 
Gene Expression in 
Human Hippocampus 
from Cocaine Abusers 






association study of 
nicotine and alcohol 
dependence in Australian 
and Dutch populations. 
18000554 





association study of 
nicotine and alcohol 
dependence in Australian 
and Dutch populations. 
18000554 






association study of 
nicotine and alcohol 
dependence in Australian 








association study of 
nicotine and alcohol 
dependence in Australian 
and Dutch populations. 
18000554 Nicotine Dependence in Dutch Sample  
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Gene set 






The dissection of 
transcriptional modules 
regulated by various drugs 
of abuse in the mouse 
striatum. 
20459597 
Genes regulated by 
methamphetamine in 
mouse striatum, 1h 
GS75635 
The dissection of 
transcriptional modules 
regulated by various drugs 
of abuse in the mouse 
striatum. 
20459597 
Genes regulated by 
methamphetamine in 
mouse striatum, 2h 
GS75636 
The dissection of 
transcriptional modules 
regulated by various drugs 
of abuse in the mouse 
striatum. 
20459597 
Genes regulated by 
methamphetamine in 
mouse striatum, 4h 
GS75637 
The dissection of 
transcriptional modules 
regulated by various drugs 
of abuse in the mouse 
striatum. 
20459597 
Genes regulated by 
methamphetamine in 
mouse striatum, 8h 
GS86511 
Methamphetamine 




events in the rat striatum. 
19564919 
Table 1: METH 
administration causes 
changes in ER stress-
related genes 
GS86571 
Distinctive profiles of gene 
expression in the human 
nucleus accumbens 
associated with cocaine 
and heroin abuse. 
16710320 NA 
GS86697 






Distinctive profiles of gene 
expression in the human 
nucleus accumbens 
associated with cocaine 




Table A1 continued. 
Gene set 








gene expression changes 
through the dopamine D1 
receptors. 
15770241 
395 genes are 
differentially down- (-) 
or up-(+ ) regulated in 
the CPu in D1 
receptor mutant mice 
compared to wild-type 
mice after repeated 
saline injections 
GS87302 
Gene expression profile of 
the nucleus accumbens of 
human cocaine abusers: 






gene expression changes 
through the dopamine D1 
receptors. 
15770241 
109 genes are 
differentially down- (-) 
or up-(+ ) regulated in 
the CPu in D1 
receptor mutant mice 
compared to wild-type 





common to human 
cocaine, cannabis and 
phencyclidine abuse. 
17205118 





phencyclidine and / or 
cannabis abusers. 
(Whole Table) [DRG] 
GS87516 
Methamphetamine 








responsive genes in 
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Gene set 















responsive genes in 
the rat striatum (372 
genes) 
GS93572 GO:0050780 dopamine receptor binding NA NA 
GS93573 GO:0050780 dopamine receptor binding NA NA 
GS94395 
GO:0060160 negative 





GO:0007191 activation of 
adenylate cyclase activity 




GO:0007195 inhibition of 
adenylate cyclase activity 
by dopamine receptor 







GS95079 GO:0031752 D5 dopamine receptor binding NA NA 
GS95081 GO:0031750 D3 dopamine receptor binding  NA NA 
GS95082 GO:0031751 D4 dopamine receptor binding NA NA 














Table A1 continued. 
Gene set 





GS95590 GO:0019811 cocaine binding NA NA 
GS95732 GO:0035240 dopamine binding  NA NA 
GS95842 GO:0007269 neurotransmitter secretion NA NA 
GS96672 GO:0042220 response to cocaine NA NA 
GS96863 




GS97110 GO:0042416 dopamine biosynthetic process  NA NA 
GS97790 
GO:0033602 negative 








GS97959 GO:0001593 dopamine D4 receptor activity NA NA 
GS97960 GO:0004952 dopamine receptor activity  NA NA 
GS97961 
GO:0001591 dopamine 
receptor activity, coupled 
viaGi/Go 
NA NA 
GS97962 GO:0001590 dopamine D1 receptor activity NA NA 
GS98438 GO:0001670 dopamine D2 receptor activity NA NA 
GS99511 
GO:0032227 negative 

















Table A1 continued. 
Gene set 





GS99535 GO:0051583 dopamine uptake  NA NA 
GS99536 
GO:0051585 negative 
regulation of dopamine 
uptake 
NA NA 
GS99537 GO:0051584 regulation of dopamine uptake  NA NA 
GS99538 
GO:0051586 positive 



















GO:0060158 activation of 
phospholipase C activity 








GS101610 GO:0031749 D2 dopamine receptor binding NA NA 
GS101611 GO:0031748 D1 dopamine receptor binding  NA NA 
GS101683 GO:0015872 dopamine transport NA NA 
GS102100 
GO:0045963 negative 
regulation of dopamine 
metabolic process 
NA NA 
GS102436 GO:0042420 dopamine catabolic process NA NA 
GS103206 
GO:0045964 positive 





Table A1 continued. 
Gene set 





GS103507 GO:0048148 behavioral response to cocaine NA NA 
GS103863 
GO:0001588 dopamine 
receptor activity, coupled 
viaGs 
NA NA 
GS103955 GO:0014059 regulation of dopamine secretion  NA NA 
GS103980 GO:0001589 dopamine D5 receptor activity NA NA 
GS104211 
GO:0033603 positive 
regulation of dopamine 
secretion 
NA NA 






GS105758 GO:0001592 dopamine D3 receptor activity NA NA 
GS107749 MP:0002556 abnormal cocaine consumption NA NA 
GS108180 MP:0004077 abnormal striatum morphology NA NA 
GS108435 
MP:0009754 enhanced 





behavioral response to 
cocaine 
NA NA 







GS110717 MP:0001906 increased dopamine level NA NA 
GS111278 MP:0005643 decreased dopamine level NA NA 
GS111849 MP:0001988 cocaine preference NA NA 
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Gene set 















GS113770 MP:0003244 loss of dopaminergic neurons  NA NA 
GS114711 Discordant Nicotine Twins Significant S-score Genes NA NA 
GS114712 
Concordant Nicotine 





for nicotine dependence 
and smoking cessation 
success in NIH research 
volunteers. 
19009022 NA 



























ABA Average Intensity for 




ABA Average Intensity for 
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Gene set 






ABA Average Intensity for 




ABA Average Intensity for 
Striatum ventral region 
Chr 15 
NA NA 
G128007 BXD SNP Count Chr4 NA NA 
GS128085 BXD SNP Count Chr 15 NA NA 
GS128080 
RhoA, encoding a 
RhoGTPase, is associated 




genes for Cocaine 
Sensitization - TOTAL 
locomotion ( cm in 1 hr) 
[Cocaine] in Females for 
Suggestive BXD QTL on 




correlations for Nucleus 
accumbens to cociane 
induced locomotor 
activation following the 





correlations for Striatum to 
cocaine induced 
locomotor activation 
following the first (10 





correlations for Nucleus 
accumbens to cocaine 
induced locomotor 
activation following the 
second (10 mg/kg) 
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Gene set 







correlations for Striatum to 
cocaine induced 
locomotor activation 
following the second (10 




Chromosomal loci that 
influence oral nicotine 
consumption in C57BL/6J 





genes for Cocaine 
Sensitization - TOTAL 
locomotion ( cm in 1 hr) 
[Cocaine] in Females for 
Suggestive BXD QTL on 
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